Golden syrian hamsters
Related publications
Behavior
Duncan, M. J., Prochot, J. R., Cook, D. H., Tyler Smith, J., & Franklin, K. M. (2013), Influence of aging on Bmal1 and Per2 expression in extra-SCN oscillators in hamster brain., Brain Research, 1491, 44-53. doi:10.1016/j.brainres.2012.11.008 [doi]
Duncan, M. J., Franklin, K. M., Peng, X., Yun, C., & Legan, S. J. (2014), Roles of exercise and arousal in blockade of the luteinizing hormone surge., hysiology & Behavior, 131, 7-16. doi:10.1016/j.physbeh.2014.04.006 [doi]
Piekarski, D. J., Jarjisian, S. G., & Zucker, I. (2012)., Winter day lengths counteract stimulatory effects of apomorphine and yohimbine on sexual behavior of male syrian hamsters., Chronobiology International, 29(7), 850-856. doi:10.3109/07420528.2012.699125 [doi]
Carcinogenesis
Santos, J. M., Havunen, R., Siurala, M., Cervera-Carrascon, V., Tahtinen, S., Sorsa, S., . . . Hemminki, A. (2017), Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy., International Journal of Cancer, 141(7), 1458-1468. doi:10.1002/ijc.30839 [doi]
Salzwedel, A. O., Han, J., LaRocca, C. J., Shanley, R., Yamamoto, M., & Davydova, J. (2018)., Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer, Oncotarget, 9(26), 18041-18052. doi:10.18632/oncotarget.24710 [doi]
Opoku-Acheampong, A. B., Penugonda, K., & Lindshield, B. L. (2016)., Effect of saw palmetto supplements on androgen-sensitive LNCaP human prostate cancer cell number and syrian hamster flank organ growth., Evidence-Based Complementary and Alternative Medicine : ECAM, 2016, 8135135. doi:10.1155/2016/8135135 [doi]
Nistal-Villan, E., Bunuales, M., Poutou, J., Gonzalez-Aparicio, M., Bravo-Perez, C., Quetglas, J. I., . . . Hernandez-Alcoceba, R. (2015)., Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a syrian hamster orthotopic pancreatic cancer model., Molecular Cancer, 14, 210-015-0479-x. doi:10.1186/s12943-015-0479-x [doi]
Woods, S. E., Ek, C., Shen, Z., Feng, Y., Ge, Z., Muthupalani, S., . . . Fox, J. G. (2016), Male syrian hamsters experimentally infected with helicobacter spp. of the H. bilis cluster develop MALT-associated gastrointestinal lymphomas., Helicobacter, 21(3), 201-217. doi:10.1111/hel.12265 [doi]
Siurala, M., Bramante, S., Vassilev, L., Hirvinen, M., Parviainen, S., Tahtinen, S., . . . Hemminki, A. (2015), Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma., International Journal of Cancer, 136(4), 945-954. doi:10.1002/ijc.29048 [doi]
LaRocca, C. J., Han, J., Gavrikova, T., Armstrong, L., Oliveira, A. R., Shanley, R., . . . Davydova, J. (2015)., Oncolytic adenovirus expressing interferon alpha in a syngeneic syrian hamster model for the treatment of pancreatic cancer., Surgery, 157(5), 888-898. doi:10.1016/j.surg.2015.01.006 [doi]
LaRocca, C. J., Han, J., Gavrikova, T., Armstrong, L., Oliveira, A. R., Shanley, R., . . . Davydova, J. (2015)., Oncolytic adenovirus expressing interferon alpha in a syngeneic syrian hamster model for the treatment of pancreatic cancer., Surgery, 157(5), 888-898. doi:10.1016/j.surg.2015.01.006 [doi]
Havunen, R., Siurala, M., Sorsa, S., Gronberg-Vaha-Koskela, S., Behr, M., Tahtinen, S., . . . Hemminki, A. (2016)., Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive cell therapy., Molecular Therapy Oncolytics, 4, 77-86. doi:10.1016/j.omto.2016.12.004 [doi]
Muhanna, N., Jin, C. S., Huynh, E., Chan, H., Qiu, Y., Jiang, W., . . . Zheng, G. (2015)., Phototheranostic porphyrin nanoparticles enable visualization and targeted treatment of head and neck cancer in clinically relevant models., Theranostics, 5(12), 1428-1443. doi:10.7150/thno.13451 [doi]
Pal, R., Shilagard, T., Yang, J., Villarreal, P., Brown, T., Qiu, S., . . . Vargas, G. (2016)., Remodeling of the epithelial-connective tissue interface in oral epithelial dysplasia as visualized by noninvasive 3D imaging., Cancer Research, 76(16), 4637-4647. doi:10.1158/0008-5472.CAN-16-0252 [doi]
Jin, J., Guo, L., VonTungeln, L., Vanlandingham, M., Cerniglia, C. E., & Chen, H. (2018), Smokeless tobacco impacts oral microbiota in a syrian golden hamster cheek pouch carcinogenesis model., Anaerobe, 52, 29-42. doi:S1075-9964(18)30095-7 [pii]
Kim, C. S., Ingato, D., Wilder-Smith, P., Chen, Z., & Kwon, Y. J. (2018)., Stimuli-disassembling gold nanoclusters for diagnosis of early stage oral cancer by optical coherence tomography., Nano Convergence, 5(1), 3-018-0134-5. Epub 2018 Jan 26. doi:10.1186/s40580-018-0134-5 [doi]
COVID-19
Ruiz-Bedoya CA, Mota F, Ordonez AA, Foss CA, Singh AK, Praharaj M, Mahmud FJ, Ghayoor A, Flavahan K, De Jesus P, Bahr M, Dhakal S, Zhou R, Solis CV, Mulka KR, Bishai WR, Pekosz A, Mankowski JL, Villano J, Klein SL, Jain SK., (124)I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection, Mol Imaging Biol. 2022 Feb;24(1):135-143. doi: 10.1007/s11307-021-01638-5. Epub 2021 Aug 23.
Ruiz-Bedoya CA, Mota F, Ordonez AA, Foss CA, Singh AK, Praharaj M, Mahmud FJ, Ghayoor A, Flavahan K, De Jesus P, Bahr M, Dhakal S, Zhou R, Solis CV, Mulka KR, Bishai WR, Pekosz A, Mankowski JL, Villano J, Klein SL, Jain SK., (124)I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection., Mol Imaging Biol. 2021 Aug 23:1-9. doi: 10.1007/s11307-021-01638-5. Online ahead of print.
Jiang L, Driedonks TAP, Jong WSP, Dhakal S, Bart van den Berg van Saparoea H, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Riley Richardson M, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton C, Mankowski JL, Luirink J, Villano JS, Witwer KW., A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants, J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192. Erratum in: J Extracell Vesicles. 2022 May;11(5):e12219.
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY., A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions, Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z. Erratum in: Nat Commun. 2022 Oct 13;13(1):6060.
Lu M, Zhang Y, Dravid P, Li A, Zeng C, Kc M, Trivedi S, Sharma H, Chaiwatpongsakorn S, Zani A, Kenney A, Cai C, Ye C, Liang X, Qiu J, Martinez-Sobrido L, Yount JS, Boyaka PN, Liu SL, Peeples ME, Kapoor A, Li J., A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters., J Virol. 2021 Sep 27;95(20):e0059221. doi: 10.1128/JVI.00592-21. Epub 2021 Aug 11.
Kolloli A, Ramasamy S, Kumar R, Nisa A, Kaplan G, Subbian S., A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection., Front Immunol. 2023 Oct 2;14:1270414. doi: 10.3389/fimmu.2023.1270414. eCollection 2023.
Huo J, Mikolajek H, Le Bas A, Clark JJ, Sharma P, Kipar A, Dormon J, Norman C, Weckener M, Clare DK, Harrison PJ, Tree JA, Buttigieg KR, Salguero FJ, Watson R, Knott D, Carnell O, Ngabo D, Elmore MJ, Fotheringham S, Harding A, MoyniĂŠ L, et al., A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19., Nat Commun. 2021 Sep 22;12(1):5469. doi: 10.1038/s41467-021-25480-z.
Wang Z, Li Z, Shi W, Zhu D, Hu S, Dinh PC, Cheng K., A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus., Sci Adv. 2023 Jun 23;9(25):eabo4100. doi: 10.1126/sciadv.abo4100. Epub 2023 Jun 23.
Campbell E, Dobkin J, Osorio LJ, Kolloli A, Ramasamy S, Kumar R, Sant'Angelo DB, Subbian S, Denzin LK, Anderson S., A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response., Vaccines (Basel). 2023 Apr 12;11(4). pii: 832. doi: 10.3390/vaccines11040832.
Maruggi G, Mallett CP, Westerbeck JW, Chen T, Lofano G, Friedrich K, Qu L, Sun JT, McAuliffe J, Kanitkar A, Arrildt KT, Wang KF, McBee I, McCoy D, Terry R, Rowles A, Abrahim MA, Ringenberg MA, Gains MJ, Spickler C, Xie X, Zou J, Shi PY, Dutt T, Henao-Tamayo M, Ragan I, Bowen RA, Johnson R, Nuti S, Luisi K, Ulmer JB, Steff AM, Jalah R, Bertholet S, Stokes AH, Yu D., A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models, Mol Ther. 2022 May 4;30(5):1897-1912. doi: 10.1016/j.ymthe.2022.01.001. Epub 2022 Jan 3.
Kurup D, Wirblich C, Zabihi Diba L, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ., A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model, Viruses. 2022 May 24;14(6). pii: 1126. doi: 10.3390/v14061126.
Liu X, Luongo C, Matsuoka Y, Park HS, Santos C, Yang L, Moore IN, Afroz S, Johnson RF, Lafont BAP, Martens C, Best SM, Munster VJ, HollĂ˝ J, Yewdell JW, Le NouĂŤn C, Munir S, Buchholz UJ., A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters., Proc Natl Acad Sci U S A. 2021 Dec 14;118(50). pii: e2109744118. doi: 10.1073/pnas.2109744118.
Ilinykh PA, Periasamy S, Huang K, Kuzmina NA, Ramanathan P, Meyer MN, Mire CE, Kuzmin IV, Bharaj P, Endsley JR, Chikina M, Sealfon SC, Widen SG, Endsley MA, Bukreyev A., A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2, NPJ Vaccines. 2022 Apr 25;7(1):47. doi: 10.1038/s41541-022-00471-3.
Zhang X, Liu Y, Liu J, Bailey AL, Plante KS, Plante JA, Zou J, Xia H, Bopp NE, Aguilar PV, Ren P, Menachery VD, Diamond MS, Weaver SC, Xie X, Shi PY., A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence., Cell. 2021 Apr 15;184(8):2229-2238.e13. doi: 10.1016/j.cell.2021.02.044. Epub 2021 Feb 23.
Lee JY, Wing PAC, Gala DS, Noerenberg M, Järvelin AI, Titlow J, Zhuang X, Palmalux N, Iselin L, Thompson MK, Parton RM, Prange-Barczynska M, Wainman A, Salguero FJ, Bishop T, Agranoff D, James W, Castello A, McKeating JA, Davis I., Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences, Elife. 2022 Jan 20;11. pii: e74153. doi: 10.7554/eLife.74153.
Yamaguchi T, Hoshizaki M, Minato T, Nirasawa S, Asaka MN, Niiyama M, Imai M, Uda A, Chan JF, Takahashi S, An J, Saku A, Nukiwa R, Utsumi D, Kiso M, Yasuhara A, Poon VK, Chan CC, Fujino Y, Motoyama S, Nagata S, Penninger JM, et al., ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury., Nat Commun. 2021 Nov 23;12(1):6791. doi: 10.1038/s41467-021-27097-8.
Wang T, Stauft C, Selvaraj P, D'agnillo F, Meseda C, Sangare K, Pedro C, Liu S, Lien C, Weir J, Starost M., Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern, Res Sq. 2022 Nov 11. pii: rs.3.rs-2227555. doi: 10.21203/rs.3.rs-2227555/v1.
Fell R, Potter JA, Yuille S, Salguero FJ, Watson R, Ngabo D, Gooch K, Hewson R, Howat D, Dowall S., Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection, Viruses. 2022 May 6;14(5). pii: 976. doi: 10.3390/v14050976.
Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE, Nekorchuk M, Busman-Sahay K, Piedra-Mora C, Wrijil LM, Ducat S, Custers J, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Lin Z, Mahrokhian SH, Nampanya F, Nityanandam R, Pessaint L, Porto M, Ali V, Benetiene D, Tevi K, Andersen H, Lewis MG, Schmidt AG, Lauffenburger DA, Alter G, Estes JD, Schuitemaker H, Zahn R, Barouch DH., Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters, Nat Med. 2020 Nov;26(11):1694-1700. doi: 10.1038/s41591-020-1070-6. Epub 2020 Sep 3.
Aid M, Vidal SJ, Piedra-Mora C, Ducat S, Chan CN, Bondoc S, Colarusso A, Starke CE, Nekorchuk M, Busman-Sahay K, Estes JD, Martinot AJ, Barouch DH., Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques, PLoS Pathog. 2022 Apr 8;18(4):e1009990. doi: 10.1371/journal.ppat.1009990. eCollection 2022 Apr.
van der Lubbe JEM, Rosendahl Huber SK, Vijayan A, Dekking L, van Huizen E, Vreugdenhil J, Choi Y, Baert MRM, Feddes-de Boer K, Izquierdo Gil A, van Heerden M, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, de Waal L, Stittelaar KJ, Tolboom JTBM, Serroyen J, Muchene L, van der Fits L, Rutten L, et al., Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease., NPJ Vaccines. 2021 Mar 19;6(1):39. doi: 10.1038/s41541-021-00301-y.
Boydston JA, Biryukov J, Yeager JJ, Zimmerman HA, Williams G, Green B, Reese AL, Beck K, Bohannon JK, Miller D, Freeburger D, Graham A, Wahl V, Hevey MC, Dabisch PA., Aerosol Particle Size Influences the Infectious Dose and Disease Severity in a Golden Syrian Hamster Model of Inhalational COVID-19., J Aerosol Med Pulm Drug Deliv. 2023 Oct;36(5):235-245. doi: 10.1089/jamp.2022.0072. Epub 2023 Jun 1.
Phillips LM, Li S, Gumin J, Daou M, Ledbetter D, Yang J, Singh S, Parker Kerrigan BC, Hossain A, Yuan Y, Gomez-Manzano C, Fueyo J, Lang FF., An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus., Neuro Oncol. 2021 Nov 2;23(11):1911-1921. doi: 10.1093/neuonc/noab128.
Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Maison RM, Gazumyan A, Martinez DR, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Bowen RA, Nussenzweig MC, Sheahan TP., Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo, J Exp Med. 2021 Mar 1;218(3):e20201993. doi: 10.1084/jem.20201993.
Lam JH, Shivhare D, Chia TW, Chew SL, Sinsinbar G, Aw TY, Wong S, Venkataraman S, Lim FWI, Vandepapeliere P, Nallani M., Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine, ACS Nano. 2022 Oct 25;16(10):16757-16775. doi: 10.1021/acsnano.2c06350. Epub 2022 Oct 12.
Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GB, Bock KW, Minai M, Nagata BM, Periasamy S, Shi PY, Graham BS, Moore IN, et al., Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection., J Clin Invest. 2021 Oct 15;131(20). pii: e148036. doi: 10.1172/JCI148036.
Vaivode K, Verhovcova I, Skrastina D, Petrovska R, Kreismane M, Lapse D, Kalnina Z, Salmina K, Rubene D, Pjanova D., Bacteriophage-Derived Double-Stranded RNA Exerts Anti-SARS-CoV-2 Activity In Vitro and in Golden Syrian Hamsters In Vivo, Pharmaceuticals (Basel). 2022 Aug 25;15(9). pii: 1053. doi: 10.3390/ph15091053.
Kaufmann E, Khan N, Tran KA, Ulndreaj A, Pernet E, Fontes G, Lupien A, Desmeules P, McIntosh F, Abow A, Moorlag SJCFM, Debisarun P, Mossman K, Banerjee A, Karo-Atar D, Sadeghi M, Mubareka S, Vinh DC, King IL, Robbins CS, Behr MA, Netea MG, Joubert P, Divangahi M., BCG vaccination provides protection against IAV but not SARS-CoV-2, Cell Rep. 2022 Mar 8;38(10):110502. doi: 10.1016/j.celrep.2022.110502. Epub 2022 Feb 21.
Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, Leung K, Wang L, Peng L, Skinner J, Li S, Wu NC, Liu H, et al., Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern., Sci Transl Med. 2021 Oct 20;13(616):eabj5413. doi: 10.1126/scitranslmed.abj5413. Epub 2021 Oct 20.
GarcÃa-Bernalt Diego J, Singh G, Jangra S, Handrejk K, Laporte M, Chang LA, El Zahed SS, Pache L, Chang MW, Warang P, Aslam S, Mena I, Webb BT, Benner C, GarcÃa-Sastre A, Schotsaert M., Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters., bioRxiv. 2023 May 23. pii: 2023.05.22.541294. doi: 10.1101/2023.05.22.541294.
Wang L, Guzman M, Muñoz-Santos D, Honrubia JM, Ripoll-Gomez J, Delgado R, Sola I, Enjuanes L, Zuñiga S., Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis., Front Cell Infect Microbiol. 2023 Oct 24;13:1268227. doi: 10.3389/fcimb.2023.1268227. eCollection 2023.
Yen HL, Valkenburg S, Sia SF, Choy KT, Peiris JSM, Wong KHM, Crossland N, Douam F, Nicholls JM., Cellular tropism of SARS-CoV-2 in the respiratory tract of Syrian hamsters and B6.Cg-Tg(K18-ACE2)2Prlmn/J transgenic mice., Vet Pathol. 2021 Sep 1:3009858211043084. doi: 10.1177/03009858211043084. [Epub ahead of print]
van Doremalen N, Schulz JE, Adney DR, Saturday TA, Fischer RJ, Yinda CK, Thakur N, Newman J, Ulaszewska M, Belij-Rammerstorfer S, Saturday G, Spencer AJ, Bailey D, Russell CA, Gilbert SC, Lambe T, Munster VJ., ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants, Nat Commun. 2022 Aug 8;13(1):4610. doi: 10.1038/s41467-022-32248-6.
Uraki R, Iida S, Halfmann PJ, Yamayoshi S, Hirata Y, Iwatsuki-Horimoto K, Kiso M, Ito M, Furusawa Y, Ueki H, Sakai-Tagawa Y, Kuroda M, Maemura T, Kim T, Mine S, Iwamoto N, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, et al., Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates., Nat Commun. 2023 Mar 23;14(1):1620. doi: 10.1038/s41467-023-37059-x.
Halfmann PJ, Kuroda M, Armbrust T, Theiler J, Balaram A, Moreno GK, Accola MA, Iwatsuki-Horimoto K, Valdez R, Stoneman E, Braun K, Yamayoshi S, Somsen E, Baczenas JJ, Mitamura K, Hagihara M, Adachi E, Koga M, McLaughlin M, Rehrauer W, Imai M, Yamamoto S, Tsutsumi T, Saito M, Friedrich TC, O'Connor SL, O'Connor DH, Gordon A, Korber B, Kawaoka Y., Characterization of the SARS-CoV-2 B.1.621 (Mu) variant, Sci Transl Med. 2022 Aug 10;14(657):eabm4908. doi: 10.1126/scitranslmed.abm4908. Epub 2022 Aug 10.
Toomer G, Burns W, Garcia L, Henry G, Biancofiori A, George A, Duffy C, Chu J, Sides M, Muñoz M, Garcia K, Nikolai-Yogerst A, Peng X, Westfall L, Baker R., Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice, Viruses. 2022 Nov 21;14(11). pii: 2584. doi: 10.3390/v14112584.
Chiba S, Kiso M, Nakajima N, Iida S, Maemura T, Kuroda M, Sato Y, Ito M, Okuda M, Yamada S, Iwatsuki-Horimoto K, Watanabe T, Imai M, Armbrust T, Baric RS, Halfmann PJ, Suzuki T, Kawaoka Y., Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model, mBio. 2022 Feb 1:e0304421. doi: 10.1128/mbio.03044-21. [Epub ahead of print]
Wussow F, Kha M, Faircloth K, Nguyen VH, Iniguez A, Martinez J, Park Y, Nguyen J, Kar S, Andersen H, Lewis MG, Chiuppesi F, Diamond DJ., COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants, iScience. 2022 Jun 17;25(6):104457. doi: 10.1016/j.isci.2022.104457. Epub 2022 May 23.
Mudrick HE, Massey S, McGlinch EB, Parrett BJ, Hemsath JR, Barry ME, Rubin JD, Uzendu C, Hansen MJ, Erskine CL, Van Keulen VP, Drelich A, Panos JA, Fida M, Suh GA, Peikert T, Block MS, Tseng CK, Olivier GR, Barry MA., Comparison of replicating and nonreplicating vaccines against SARS-CoV-2, Sci Adv. 2022 Aug 26;8(34):eabm8563. doi: 10.1126/sciadv.abm8563. Epub 2022 Aug 24.
Ramasamy S, Kolloli A, Kumar R, Husain S, Soteropoulos P, Chang TL, Subbian S., Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection, Biomedicines. 2022 Jun 7;10(6). pii: 1343. doi: 10.3390/biomedicines10061343.
King HAD, Dussupt V, Mendez-Rivera L, Slike BM, Tran U, Jackson ND, Barkei E, Zemil M, Tourtellott-Fogt E, Kuklis CH, Soman S, Ahmed A, Porto M, Kitajewski C, Spence B, Benetiene D, Wieczorek L, Kar S, Gromowski G, Polonis VR, Krebs SJ, Modjarrad K, et al., Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters., Front Immunol. 2023 Mar 21;14:1138629. doi: 10.3389/fimmu.2023.1138629. eCollection 2023.
Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, Soto Albrecht Y, Murdock DG, Angelin A, Singh LN, Weiss SL, Best SM, Lott MT, Zhang S, Cope H, Zaksas V, Saravia-Butler A, Meydan C, Foox J, Mozsary C, Bram Y, Kidane Y, et al., Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts., Sci Transl Med. 2023 Aug 9;15(708):eabq1533. doi: 10.1126/scitranslmed.abq1533. Epub 2023 Aug 9.
Rosenke K, Meade-White K, Letko M, Clancy C, Hansen F, Liu Y, Okumura A, Tang-Huau TL, Li R, Saturday G, Feldmann F, Scott D, Wang Z, Munster V, Jarvis MA, Feldmann H., Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection, Emerg Microbes Infect. 2020 Nov 29:1-36. doi: 10.1080/22221751.2020.1858177. Online ahead of print.
Andrade VM, Maricic I, Kalia R, Jachimowicz L, Bedoya O, Kulp DW, Humeau L, Smith TRF., Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models., Hum Vaccin Immunother. 2023 Dec 15;19(3):2281733. doi: 10.1080/21645515.2023.2281733. Epub 2023 Nov 27.
Liu Y, Liu J, Johnson BA, Xia H, Ku Z, Schindewolf C, Widen SG, An Z, Weaver SC, Menachery VD, Xie X, Shi PY., Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant, Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829. Epub 2022 Apr 29.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Humphries G, Schuhmann H, Ngabo D, Rayner E, Otter AD, Coleman T, Hicks B, Graham VA, Halkerston R, Apostolakis K, Taylor S, Fotheringham S, Horton A, Tree JA, Wand M, Hewson R, Dowall SD., Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins, Antiviral Res. 2022 Jul;203:105332. doi: 10.1016/j.antiviral.2022.105332. Epub 2022 May 6.
Dowall S, Salguero FJ, Wiblin N, Fotheringham S, Hatch G, Parks S, Gowan K, Harris D, Carnell O, Fell R, Watson R, Graham V, Gooch K, Hall Y, Mizen S, Hewson R., Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection., Viruses. 2021 Nov 9;13(11). pii: 2251. doi: 10.3390/v13112251.
Parzych EM, Du J, Ali AR, Schultheis K, Frase D, Smith TRF, Cui J, Chokkalingam N, Tursi NJ, Andrade VM, Warner BM, Gary EN, Li Y, Choi J, Eisenhauer J, Maricic I, Kulkarni A, Chu JD, Villafana G, Rosenthal K, Ren K, Francica JR, Wootton SK, Tebas P, Kobasa D, Broderick KE, Boyer JD, Esser MT, Pallesen J, Kulp DW, Patel A, Weiner DB., DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2, Nat Commun. 2022 Oct 6;13(1):5886. doi: 10.1038/s41467-022-33309-6.
Hajnik RL, Plante JA, Liang Y, Alameh MG, Tang J, Bonam SR, Zhong C, Adam A, Scharton D, Rafael GH, Liu Y, Hazell NC, Sun J, Soong L, Shi PY, Wang T, Walker DH, Sun J, Weissman D, Weaver SC, Plante KS, Hu H., Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models, Sci Transl Med. 2022 Sep 14;14(662):eabq1945. doi: 10.1126/scitranslmed.abq1945. Epub 2022 Sep 14.
Halfmann PJ, Kuroda M, Maemura T, Chiba S, Armbrust T, Wright R, Balaram A, Florek KR, Bateman AC, Kawaoka Y., Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters, Cell Rep. 2022 Apr 19;39(3):110688. doi: 10.1016/j.celrep.2022.110688. Epub 2022 Mar 28.
Cong Y, Mucker EM, Perry DL, Dixit S, Kollins E, Byrum R, Huzella L, Kim R, Josleyn M, Kwilas S, Stefan C, Shoemaker CJ, Koehler J, Coyne S, Delp K, Liang J, Drawbaugh D, Hischak A, Hart R, Postnikova E, Vaughan N, Asher J, et al., Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters., Antiviral Res. 2023 May;213:105589. doi: 10.1016/j.antiviral.2023.105589. Epub 2023 Mar 30.
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, Li Z, Beck SE, Witwer KW, Mankowski JL, Ramanathan M, Rowan NR, Lane AP., Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants, bioRxiv. 2022 Apr 12. pii: 2022.04.12.487379. doi: 10.1101/2022.04.12.487379.
Wang Z, Popowski KD, Zhu D, de Juan Abad BL, Wang X, Liu M, Lutz H, De Naeyer N, DeMarco CT, Denny TN, Dinh PC, Li Z, Cheng K., Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine, Nat Biomed Eng. 2022 Jul;6(7):791-805. doi: 10.1038/s41551-022-00902-5. Epub 2022 Jul 4.
Johnson BA, Xie X, Kalveram B, Lokugamage KG, Muruato A, Zou J, Zhang X, Juelich T, Smith JK, Zhang L, Bopp N, Schindewolf C, Vu M, Vanderheiden A, Swetnam D, Plante JA, Aguilar P, Plante KS, Lee B, Weaver SC, Suthar MS, Routh AL, Ren P, Ku Z, An Z, Debbink K, Shi PY, Freiberg AN, Menachery VD., Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis, bioRxiv. 2020 Aug 26:2020.08.26.268854. doi: 10.1101/2020.08.26.268854. Preprint.
Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., ... & Cornelius, A., Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates, bioRxiv. 2020. November 20, 2020. doi: https://doi.org/10.1101/2020.08.25.256339
Wing PAC, Prange-Barczynska M, Cross A, Crotta S, Orbegozo Rubio C, Cheng X, Harris JM, Zhuang X, Johnson RL, Ryan KA, Hall Y, Carroll MW, Issa F, Balfe P, Wack A, Bishop T, Salguero FJ, McKeating JA., Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model, PLoS Pathog. 2022 Sep 6;18(9):e1010807. doi: 10.1371/journal.ppat.1010807. eCollection 2022 Sep.
Nikitin PA, DiMuzio JM, Dowling JP, Patel NB, Bingaman-Steele JL, Heimbach BC, Henriquez N, Nicolescu C, Polley A, Sikorski EL, Howanski RJ, Nath M, Shukla H, Scheaffer SM, Finn JP, Liang LF, Smith T, Storm N, McKay LGA, Johnson RI, Malsick LE, Honko AN, Griffiths A, Diamond MS, Sarma P, Geising DH, Morin MJ, Robinson MK., IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2, Sci Immunol. 2022 Sep 9;7(75):eabl9943. doi: 10.1126/sciimmunol.abl9943. Epub 2022 Sep 9.
Field CJ, Heinly TA, Patel DR, Sim DG, Luley E, Gupta SL, Vanderford TH, Wrammert J, Sutton TC., Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters, Emerg Microbes Infect. 2022 Dec;11(1):1103-1114. doi: 10.1080/22221751.2022.2058419.
Tostanoski LH, Yu J, Mercado NB, McMahan K, Jacob-Dolan C, Martinot AJ, Piedra-Mora C, Anioke T, Chang A, Giffin VM, Hope DL, Wan H, Bondzie EA, Mahrokhian SH, Wrijil LM, Bauer K, Pessaint L, Porto M, Piegols J, Faudree A, Spence B, Kar S, et al., Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern., Sci Transl Med. 2021 Nov 3;13(618):eabj3789. doi: 10.1126/scitranslmed.abj3789. Epub 2021 Nov 3.
Machado RRG, Walker JL, Scharton D, Rafael GH, Mitchell BM, Reyna RA, de Souza WM, Liu J, Walker DH, Plante JA, Plante KS, Weaver SC., Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters., Nat Commun. 2023 Jul 17;14(1):4260. doi: 10.1038/s41467-023-40033-2.
Sayedahmed EE, Araújo MV, Silva-Pereira TT, Chothe SK, Elkashif A, Alhashimi M, Wang WC, Santos AP, Nair MS, Gontu A, Nissly R, Francisco de Souza Filho A, Tavares MS, Ayupe MC, Salgado CL, Donizetti de Oliveira Candido É, Leal Oliveira DB, Durigon EL, Heinemann MB, Morais da Fonseca D, Jagannath C, Sá Guimarães AM, et al., Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine., Mol Ther Methods Clin Dev. 2023 Jun 27;30:194-207. doi: 10.1016/j.omtm.2023.06.009. eCollection 2023 Sep 14.
Kehrer T, Cupic A, Ye C, Yildiz S, Bouhhadou M, Crossland NA, Barrall E, Cohen P, Tseng A, Çağatay T, Rathnasinghe R, Flores D, Jangra S, Alam F, Mena N, Aslam S, Saqi A, Marin A, Rutkowska M, Ummadi MR, Pisanelli G, Richardson RB, Veit EC, Fabius JM, Soucheray M, Polacco BJ, Evans MJ, Swaney DL, Gonzalez-Reiche AS, Sordillo EM, van Bakel H, Simon V, Zuliani-Alvarez L, Fontoura BMA, Rosenberg BR, Krogan NJ, Martinez-Sobrido L, García-Sastre A, Miorin L., Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis, bioRxiv. 2022 Nov 30. pii: 2022.10.18.512708. doi: 10.1101/2022.10.18.512708.
Kehrer T, Cupic A, Ye C, Yildiz S, Bouhaddou M, Crossland NA, Barrall EA, Cohen P, Tseng A, Çağatay T, Rathnasinghe R, Flores D, Jangra S, Alam F, Mena I, Aslam S, Saqi A, Rutkowska M, Ummadi MR, Pisanelli G, Richardson RB, Veit EC, et al., Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis., Cell Host Microbe. 2023 Oct 11;31(10):1668-1684.e12. doi: 10.1016/j.chom.2023.08.003. Epub 2023 Sep 21.
Kurup D, Malherbe DC, Wirblich C, Lambert R, Ronk AJ, Zabihi Diba L, Bukreyev A, Schnell MJ., Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model., PLoS Pathog. 2021 Mar 25;17(3):e1009383. doi: 10.1371/journal.ppat.1009383. eCollection 2021 Mar.
Port JR, Yinda CK, Avanzato VA, Schulz JE, Holbrook MG, van Doremalen N, Shaia C, Fischer RJ, Munster VJ., Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo, Nat Microbiol. 2022 Feb;7(2):213-223. doi: 10.1038/s41564-021-01047-y. Epub 2022 Jan 11.
Port JR, Yinda CK, Riopelle JC, Weishampel ZA, Saturday TA, Avanzato VA, Schulz JE, Holbrook MG, Barbian K, Perry-Gottschalk R, Haddock E, Martens C, Shaia CI, Lambe T, Gilbert SC, van Doremalen N, Munster VJ., Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters., Nat Commun. 2023 Oct 18;14(1):6592. doi: 10.1038/s41467-023-42346-8.
Hawks SA, Prussin AJ 2nd, Kuchinsky SC, Pan J, Marr LC, Duggal NK., Infectious SARS-CoV-2 Is Emitted in Aerosol Particles., mBio. 2021 Oct 26;12(5):e0252721. doi: 10.1128/mBio.02527-21. Epub 2021 Oct 19.
Yang Z, Johnson BA, Meliopoulos VA, Ju X, Zhang P, Hughes MP, Wu J, Koreski KP, Chang TC, Wu G, Hixon J, Duffner J, Wong K, Lemieux R, Lokugamage KG, Alvardo RE, Crocquet-Valdes PA, Walker DH, Plante KS, Plante JA, Weaver SC, Kim HJ, et al., Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication., bioRxiv. 2023 Jun 30. pii: 2023.06.29.546885. doi: 10.1101/2023.06.29.546885.
Liu S, Stauft CB, Selvaraj P, Chandrasekaran P, D'Agnillo F, Chou CK, Wu WW, Lien CZ, Meseda CA, Pedro CL, Starost MF, Weir JP, Wang TT., Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters, Nat Commun. 2022 Nov 10;13(1):6792. doi: 10.1038/s41467-022-34571-4.
Park HS, Matsuoka Y, Luongo C, Yang L, Santos C, Liu X, Ahlers LRH, Moore IN, Afroz S, Johnson RF, Lafont BAP, Dorward DW, Fischer ER, Martens C, Samal SK, Munir S, Buchholz UJ, Le Nouën C., Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2, NPJ Vaccines. 2022 Jun 28;7(1):72. doi: 10.1038/s41541-022-00493-x.
Baldeon Vaca G, Meyer M, Cadete A, Hsiao CJ, Golding A, Jeon A, Jacquinet E, Azcue E, Guan CM, Sanchez-Felix X, Pietzsch CA, Mire CE, Hyde MA, Comeaux ME, Williams JM, Sung JC, Carfi A, Edwards DK, Bukreyev A, Bahl K., Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection., Sci Adv. 2023 Sep 22;9(38):eadh1655. doi: 10.1126/sciadv.adh1655. Epub 2023 Sep 22.
Patel DR, Minns AM, Sims DG, Field CJ, Kerr AE, Heinly T, Luley EH, Rossi RM, Bator C, Mostafa IM, Hafenstein SL, Lindner SE, Sutton TC., Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model, bioRxiv. 2022 Dec 14. pii: 2022.10.27.514054. doi: 10.1101/2022.10.27.514054.
Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Gupta M, Srikrishna G, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Creisher PS, Li M, Pekosz A, Klein SL, Jain SK, Bivalacqua TJ, et al., Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells., iScience. 2023 Aug 24;26(10):107733. doi: 10.1016/j.isci.2023.107733. eCollection 2023 Oct 20.
Wheatley AK, Pymm P, Esterbauer R, Dietrich MH, Lee WS, Drew D, Kelly HG, Chan LJ, Mordant FL, Black KA, Adair A, Tan HX, Juno JA, Wragg KM, Amarasena T, Lopez E, Selva KJ, Haycroft ER, Cooney JP, Venugopal H, Tan LL, O Neill MT, et al., Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain., Cell Rep. 2021 Oct 12;37(2):109822. doi: 10.1016/j.celrep.2021.109822. Epub 2021 Sep 25.
Liu X, Park HS, Matsuoka Y, Santos C, Yang L, Luongo C, Moore IN, Johnson RF, Garza NL, Zhang P, Lusso P, Best SM, Buchholz UJ, Le Nouën C., Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters., PLoS Pathog. 2023 Jun 23;19(6):e1011057. doi: 10.1371/journal.ppat.1011057. eCollection 2023 Jun.
Cong Y, Lee JH, Perry DL, Cooper K, Wang H, Dixit S, Liu DX, Feuerstein IM, Solomon J, Bartos C, Seidel J, Hammoud DA, Adams R, Anthony SM, Liang J, Schuko N, Li R, Liu Y, Wang Z, Tarbet EB, Hischak AMW, Hart R, et al., Longitudinal analyses using (18)F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models., Antiviral Res. 2023 Jun;214:105605. doi: 10.1016/j.antiviral.2023.105605. Epub 2023 Apr 15.
Halfmann PJ, Kuroda M, Armbrust T, Accola M, Valdez R, Kowalski-Dobson T, Rehrauer W, Gordon A, Kawaoka Y., Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model, Cell Rep. 2022 Feb 15;38(7):110394. doi: 10.1016/j.celrep.2022.110394. Epub 2022 Jan 31.
Vu MN, Alvarado RE, Morris DR, Lokugamage KG, Zhou Y, Morgan AL, Estes LK, McLeland AM, Schindewolf C, Plante JA, Ahearn YP, Meyers WM, Murray JT, Crocquet-Valdes PA, Weaver SC, Walker DH, Russell WK, Routh AL, Plante KS, Menachery V., Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection., bioRxiv. 2023 Jul 10. pii: 2023.04.17.536926. doi: 10.1101/2023.04.17.536926.
Choudhary S, Kanevsky I, Yildiz S, Sellers RS, Swanson KA, Franks T, Rathnasinghe R, Munoz-Moreno R, Jangra S, Gonzalez O, Meade P, Coskran T, Qian J, Lanz TA, Johnson JG, Tierney CA, Smith JD, Tompkins K, Illenberger A, Corts P, Ciolino T, Dormitzer PR, Dick EJ Jr, Shivanna V, Hall-Ursone S, Cole J, Kaushal D, Fontenot JA, Martinez-Romero C, McMahon M, Krammer F, Schotsaert M, García-Sastre A., Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models, Toxicol Pathol. 2022 Apr;50(3):280-293. doi: 10.1177/01926233211072767. Epub 2022 Feb 5.
Rosenke K, Okumura A, Lewis MC, Feldmann F, Meade-White K, Bohler WF, Griffin A, Rosenke R, Shaia C, Jarvis MA, Feldmann H., Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model, JCI Insight. 2022 Jul 8;7(13). pii: e160108. doi: 10.1172/jci.insight.160108.
Rauch S, Roth N, Schwendt K, Fotin-Mleczek M, Mueller SO, Petsch B., mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents, bioRxiv 2020.10.23.351775; doi: https://doi.org/10.1101/2020.10.23.351775
Rauch S, Roth N, Schwendt K, Fotin-Mleczek M, Mueller SO, Petsch B., mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents., NPJ Vaccines. 2021 Apr 16;6(1):57. doi: 10.1038/s41541-021-00311-w.
Keitany GJ, Rubin BER, Garrett ME, Musa A, Tracy J, Liang Y, Ebert P, Moore AJ, Guan J, Eggers E, Lescano N, Brown R, Carbo A, Al-Asadi H, Ching T, Day A, Harris R, Linkem C, Popov D, Wilkins C, Li L, Wang J, et al., Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells., Cell Chem Biol. 2023 Nov 16;30(11):1377-1389.e8. doi: 10.1016/j.chembiol.2023.07.011. Epub 2023 Aug 15.
Halfmann PJ, Frey SJ, Loeffler K, Kuroda M, Maemura T, Armbrust T, Yang JE, Hou YJ, Baric R, Wright ER, Kawaoka Y, Kane RS., Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses, EBioMedicine. 2022 Dec;86:104341. doi: 10.1016/j.ebiom.2022.104341. Epub 2022 Nov 11.
Assmus F, Driouich JS, Abdelnabi R, Vangeel L, Touret F, Adehin A, Chotsiri P, Cochin M, Foo CS, Jochmans D, Kim S, Luciani L, Moureau G, Park S, Pétit PR, Shum D, Wattanakul T, Weynand B, Fraisse L, Ioset JR, Mowbray CE, Owen A, Hoglund RM, Tarning J, Lamballerie X, Nougairède A, Neyts J, Sjö P, Escudié F, Scandale I, Chatelain E., Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19, Microorganisms. 2022 Aug 12;10(8). pii: 1639. doi: 10.3390/microorganisms10081639.
Konrath KM, Liaw K, Wu Y, Zhu X, Walker SN, Xu Z, Schultheis K, Chokkalingam N, Chawla H, Du J, Tursi NJ, Moore A, Adolf-Bryfogle J, Purwar M, Reuschel EL, Frase D, Sullivan M, Fry B, Maricic I, Andrade VM, Iffland C, Crispin M, Broderick KE, Humeau LMPF, Patel A, Smith TRF, Pallesen J, Weiner DB, Kulp DW., Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection, Cell Rep. 2022 Feb 1;38(5):110318. doi: 10.1016/j.celrep.2022.110318. Epub 2022 Jan 11.
Johnson BA, Zhou Y, Lokugamage KG, Vu MN, Bopp N, Crocquet-Valdes PA, Kalveram B, Schindewolf C, Liu Y, Scharton D, Plante JA, Xie X, Aguilar P, Weaver SC, Shi PY, Walker DH, Routh AL, Plante KS, Menachery VD., Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis, PLoS Pathog. 2022 Jun 21;18(6):e1010627. doi: 10.1371/journal.ppat.1010627. eCollection 2022 Jun.
Merino VF, Yan Y, Ordonez AA, Bullen CK, Lee A, Saeki H, Ray K, Huang T, Jain SK, Pomper MG., Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells., Antiviral Res. 2023 Mar;211:105550. doi: 10.1016/j.antiviral.2023.105550. Epub 2023 Feb 3.
Weishampel ZA, Young J, Fischl M, Fischer RJ, Donkor IO, Riopelle JC, Schulz JE, Port JR, Saturday TA, van Doremalen N, Berry JD, Munster VJ, Yinda CK., OraSure InteliSwab(™) Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern-Alpha, Beta, Gamma, Delta, and Omicron, Viruses. 2022 Mar 6;14(3). pii: 543. doi: 10.3390/v14030543.
Fisher T, Gluck A, Narayanan K, Kuroda M, Nachshon A, Hsu JC, Halfmann PJ, Yahalom-Ronen Y, Tamir H, Finkel Y, Schwartz M, Weiss S, Tseng CK, Israely T, Paran N, Kawaoka Y, Makino S, Stern-Ginossar N., Parsing the role of NSP1 in SARS-CoV-2 infection, Cell Rep. 2022 Jun 14;39(11):110954. doi: 10.1016/j.celrep.2022.110954. Epub 2022 May 26.
Tostanoski LH, Chandrashekar A, Patel S, Yu J, Jacob-Dolan C, Chang A, Powers OC, Sellers D, Gardner S, Barrett J, Sanborn O, Stephenson KE, Ansel JL, Jaegle K, Seaman MS, Porto M, Lok M, Spence B, Cayer K, Nase D, Holman S, Bradette H, Kar S, Andersen H, Lewis MG, Cox F, Tolboom JTBM, de Groot AM, Heerwegh D, Le Gars M, Sadoff J, Wegmann F, Zahn RC, Schuitemaker H, Barouch DH., Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters, NPJ Vaccines. 2022 Jan 10;7(1):2. doi: 10.1038/s41541-021-00427-z.
O'Donnell KL, Pinski AN, Clancy CS, Gourdine T, Shifflett K, Fletcher P, Messaoudi I, Marzi A., Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model., EBioMedicine. 2021 Nov;73:103675. doi: 10.1016/j.ebiom.2021.103675. Epub 2021 Nov 7.
Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, Wang T, Golding B., Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters., Clin Infect Dis. 2021 Sep 23. pii: ciab854. doi: 10.1093/cid/ciab854. [Epub ahead of print]
Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, Wang T, Golding B., Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Adult Syrian Hamsters, Clin Infect Dis. 2022 Aug 24;75(1):e459-e465. doi: 10.1093/cid/ciab854.
Meehan GR, Herder V, Allan J, Huang X, Kerr K, Mendonca DC, Ilia G, Wright DW, Nomikou K, Gu Q, Molina Arias S, Hansmann F, Hardas A, Attipa C, De Lorenzo G, Cowton V, Upfold N, Palmalux N, Brown JC, Barclay WS, Filipe ADS, Furnon W, et al., Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning., PLoS Pathog. 2023 Nov 7;19(11):e1011589. doi: 10.1371/journal.ppat.1011589. eCollection 2023 Nov.
Roh J, Kitchen R, Guseh JS, McNeill J, Aid M, Martinot A, Yu A, Platt C, Rhee J, Weber B, Trager L, Hastings M, Ducat S, Xia P, Castro C, Atlason B, Churchill T, Carli MD, Ellinor P, Barouch D, Ho J, Rosenzweig A., Plasma Proteomics of COVID-19 Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics., Res Sq. 2021 Jun 8. pii: rs.3.rs-539712. doi: 10.21203/rs.3.rs-539712/v1.
Roh JD, Kitchen RR, Guseh JS, McNeill JN, Aid M, Martinot AJ, Yu A, Platt C, Rhee J, Weber B, Trager LE, Hastings MH, Ducat S, Xia P, Castro C, Singh A, Atlason B, Churchill TW, Di Carli MF, Ellinor PT, Barouch DH, Ho JE, Rosenzweig A., Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics, JACC Basic Transl Sci. 2022 May;7(5):425-441. doi: 10.1016/j.jacbts.2022.01.013. Epub 2022 May 4.
Chen Z, Zhang P, Matsuoka Y, Tsybovsky Y, West K, Santos C, Boyd LF, Nguyen H, Pomerenke A, Stephens T, Olia AS, Zhang B, De Giorgi V, Holbrook MR, Gross R, Postnikova E, Garza NL, Johnson RF, Margulies DH, Kwong PD, Alter HJ, Buchholz UJ, Lusso P, Farci P., Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants, Cell Rep. 2022 Nov 1;41(5):111528. doi: 10.1016/j.celrep.2022.111528. Epub 2022 Sep 30.
Piepenbrink MS, Park JG, Deshpande A, Loos A, Ye C, Basu M, Sarkar S, Khalil AM, Chauvin D, Woo J, Lovalenti P, Erdmann NB, Goepfert PA, Truong VL, Bowen RA, Walter MR, Martinez-Sobrido L, Kobie JJ., Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody, PLoS Pathog. 2022 Jul 21;18(7):e1010691. doi: 10.1371/journal.ppat.1010691. eCollection 2022 Jul.
Espeseth AS, Yuan M, Citron M, Reiserova L, Morrow G, Wilson A, Horton M, Rukhman M, Kinek K, Hou F, Li SL, Li F, Choi Y, Heidecker G, Luo B, Wu G, Zhang L, Strable E, DeStefano J, Secore S, Mukhopadhyay TK, Richardson DD, Sayeed E, Welch LS, Bett AJ, Feinberg MB, Gupta SB, Cooper CL, Parks CL., Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera, EBioMedicine. 2022 Aug;82:104203. doi: 10.1016/j.ebiom.2022.104203. Epub 2022 Jul 30.
Yinda CK, Port JR, Bushmaker T, Fischer RJ, Schulz JE, Holbrook MG, Shaia C, de Wit E, van Doremalen N, Munster VJ., Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant., Emerg Microbes Infect. 2021 Dec;10(1):1284-1292. doi: 10.1080/22221751.2021.1943539.
Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, et al., Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets., Immunity. 2021 Jun 8;54(6):1290-1303.e7. doi: 10.1016/j.immuni.2021.05.001. Epub 2021 May 6.
Mulka KR, Beck SE, Solis CV, Johanson AL, Queen SE, McCarron ME, Richardson MR, Zhou R, Marinho P, Jedlicka A, Guerrero-Martin S, Shirk EN, Braxton AM, Brockhurst J, Creisher PS, Dhakal S, Brayton CF, Veenhuis RT, Metcalf Pate KA, Karakousis PC, Zahnow CA, Klein SL, Jain SK, Tarwater PM, Pekosz AS, Villano JS, Mankowski JL; Johns Hopkins COVID-19 Hamster Study Group., Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters, Am J Pathol. 2022 Feb;192(2):195-207. doi: 10.1016/j.ajpath.2021.10.009. Epub 2021 Nov 10.
Mulka KR, Beck SE, Solis CV, Johanson AL, Queen SE, McCarron ME, Richardson MR, Zhou R, Marinho P, Jedlicka A, Guerrero-Martin S, Shirk EN, Braxton AM, Brockhurst J, Creisher PS, Dhakal S, Brayton CF, Veenhuis RT, Metcalf Pate KA, Karakousis PC, Zahnow CA, Klein SL, et al., Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters., Am J Pathol. 2021 Nov 10. pii: S0002-9440(21)00472-7. doi: 10.1016/j.ajpath.2021.10.009. [Epub ahead of print]
Sui Y, Andersen H, Li J, Hoang T, Bekele Y, Kar S, Lewis MG, Berzofsky JA., Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants., Front Immunol. 2023 Mar 20;14:1154496. doi: 10.3389/fimmu.2023.1154496. eCollection 2023.
Gagne M, Corbett KS, Flynn BJ, Foulds KE, Wagner DA, Andrew SF, Todd JM, Honeycutt CC, McCormick L, Nurmukhambetova ST, Davis-Gardner ME, Pessaint L, Bock KW, Nagata BM, Minai M, Werner AP, Moliva JI, Tucker C, Lorang CG, Zhao B, McCarthy E, Cook A, Dodson A, Teng IT, Mudvari P, Roberts-Torres J, Laboune F, Wang L, Goode A, Kar S, Boyoglu-Barnum S, Yang ES, Shi W, Ploquin A, Doria-Rose N, Carfi A, Mascola JR, Boritz EA, Edwards DK, Andersen H, Lewis MG, Suthar MS, Graham BS, Roederer M, Moore IN, Nason MC, Sullivan NJ, Douek DC, Seder RA., Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung, Cell. 2022 Jan 6;185(1):113-130.e15. doi: 10.1016/j.cell.2021.12.002. Epub 2021 Dec 3.
Vu MN, Lokugamage KG, Plante JA, Scharton D, Bailey AO, Sotcheff S, Swetnam DM, Johnson BA, Schindewolf C, Alvarado RE, Crocquet-Valdes PA, Debbink K, Weaver SC, Walker DH, Russell WK, Routh AL, Plante KS, Menachery VD., QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis, Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2205690119. doi: 10.1073/pnas.2205690119. Epub 2022 Jul 26.
Dacon C, Peng L, Lin TH, Tucker C, Lee CD, Cong Y, Wang L, Purser L, Cooper AJR, Williams JK, Pyo CW, Yuan M, Kosik I, Hu Z, Zhao M, Mohan D, Peterson M, Skinner J, Dixit S, Kollins E, Huzella L, Perry D, Byrum R, Lembirik S, Murphy M, Zhang Y, Yang ES, Chen M, Leung K, Weinberg RS, Pegu A, Geraghty DE, Davidson E, Doranz BJ, Douagi I, Moir S, Yewdell JW, Schmaljohn C, Crompton PD, Mascola JR, Holbrook MR, Nemazee D, Wilson IA, Tan J., Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses, Cell Host Microbe. 2023 Jan 11;31(1):97-111.e12. doi: 10.1016/j.chom.2022.10.010. Epub 2022 Nov 7.
Zhang Y, Lu M, Thongpan I, Xu J, Kc M, Dravid P, Trivedi S, Sharma H, Liang X, Kapoor A, Peeples ME, Li J., Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection., J Med Virol. 2023 Apr;95(4):e28687. doi: 10.1002/jmv.28687.
McMahan K, Giffin V, Tostanoski LH, Chung B, Siamatu M, Suthar MS, Halfmann P, Kawaoka Y, Piedra-Mora C, Jain N, Ducat S, Kar S, Andersen H, Lewis MG, Martinot AJ, Barouch DH., Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters, Med (N Y). 2022 Apr 8;3(4):262-268.e4. doi: 10.1016/j.medj.2022.03.004. Epub 2022 Mar 17.
Piedra-Mora C, Robinson SR, Tostanoski LH, Dayao DAE, Chandrashekar A, Bauer K, Wrijil L, Ducat S, Hayes T, Yu J, Bondzie EA, McMahan K, Sellers D, Giffin V, Hope D, Nampanya F, Mercado NB, Kar S, Andersen H, Tzipori S, Barouch DH, Martinot AJ., Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments, Vet Pathol. 2022 Jul;59(4):648-660. doi: 10.1177/03009858221095794. Epub 2022 May 6.
Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Aldridge M, Humphries G, Schuhmann H, Ngabo D, Rayner E, Otter A, Coleman T, Hicks B, Halkerston R, Apostolakis K, Taylor S, Fotheringham S, Horton A, CanoCejas I, Wand M, Tree JA, Sutton M, Graham V, et al., Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')(2) fragments., Sci Rep. 2023 Aug 25;13(1):13912. doi: 10.1038/s41598-023-40277-4. Erratum in: Sci Rep. 2023 Sep 18;13(1):15419.
Štrbenc, M., Kuhar, U., Lainšček, D., Orehek, S., Slavec, B., Krapež, U., Malovrh, T., & Majdič, G., Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research., Animals (Basel). 2023 Aug 14;13(16). pii: 2616. doi: 10.3390/ani13162616.
Hawman DW, Meade-White K, Clancy C, Archer J, Hinkley T, Leventhal SS, Rao D, Stamper A, Lewis M, Rosenke R, Krieger K, Randall S, Khandhar AP, Hao L, Hsiang TY, Greninger AL, Gale M Jr, Berglund P, Fuller DH, Rosenke K, Feldmann H, Erasmus JH., Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine, EBioMedicine. 2022 Sep;83:104196. doi: 10.1016/j.ebiom.2022.104196. Epub 2022 Aug 4.
Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH 3rd, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Graham R, Edwards CE, Tse LV, Okuda K, Markmann AJ, Bartelt L, de Silva A, Margolis DM, Boucher RC, Randell SH, Suzuki T, Gralinski LE, Kawaoka Y, Baric RS., SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo, Science. 2020 Nov 12:eabe8499. doi: 10.1126/science.abe8499. Online ahead of print.
Port JR, Yinda CK, Owusu IO, Holbrook M, Fischer R, Bushmaker T, Avanzato VA, Schulz JE, Martens C, van Doremalen N, Clancy CS, Munster VJ., SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters., Nat Commun. 2021 Aug 17;12(1):4985. doi: 10.1038/s41467-021-25156-8.
Handley A, Ryan KA, Davies ER, Bewley KR, Carnell OT, Challis A, Coombes NS, Fotheringham SA, Gooch KE, Charlton M, Harris DJ, Kennard C, Ngabo D, Weldon TM, Salguero FJ, Funnell SGP, Hall Y., SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum., Viruses. 2023 Mar 14;15(3). pii: 748. doi: 10.3390/v15030748.
Garvanska DH, Alvarado RE, Mundt FO, Nilsson E, Duel JK, Coscia F, Lindqvist R, Lokugamage K, Johnson BA, Plante JA, Morris DR, Vu MN, Estes LK, McLeland AM, Walker J, Crocquet-Valdes PA, Mendez BL, Plante KS, Walker DH, Weisser MB, Overby AK, Mann M, et al., SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection., bioRxiv. 2023 Sep 1. pii: 2023.09.01.555899. doi: 10.1101/2023.09.01.555899.
Selvaraj P, Lien CZ, Liu S, Stauft CB, Nunez IA, Hernandez M, Nimako E, Ortega MA, Starost MF, Dennis JU, Wang TT., SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters., Life Sci Alliance. 2021 Feb 11;4(4). pii: e202000886. doi: 10.26508/lsa.202000886. Print 2021 Apr.
Halfmann PJ, Nakajima N, Sato Y, Takahashi K, Accola M, Chiba S, Fan S, Neumann G, Rehrauer W, Suzuki T, Kawaoka Y., SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters, J Infect Dis. 2022 Jan 18;225(2):282-286. doi: 10.1093/infdis/jiab587.
Halfmann P, Nakajima N, Sato Y, Takahashi K, Accola M, Chibo S, Fan S, Neumann G, Rehrauer W, Suzuki T, Kawaoka Y., SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters., J Infect Dis. 2021 Dec 7. pii: jiab587. doi: 10.1093/infdis/jiab587. [Epub ahead of print]
Sui Y, Andersen H, Li J, Hoang T, Minai M, Nagata BM, Bock KW, Alves DA, Lewis MG, Berzofsky JA., SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy., Vaccine. 2024 Jan 12;42(2):339-351. doi: 10.1016/j.vaccine.2023.11.059. Epub 2023 Dec 8.
Halfmann PJ, Iida S, Iwatsuki-Horimoto K, Maemura T, Kiso M, Scheaffer SM, Darling TL, Joshi A, Loeber S, Singh G, Foster SL, Ying B, Case JB, Chong Z, Whitener B, Moliva J, Floyd K, Ujie M, Nakajima N, Ito M, Wright R, Uraki R, Warang P, Gagne M, Li R, Sakai-Tagawa Y, Liu Y, Larson D, Osorio JE, Hernandez-Ortiz JP, Henry AR, Ciuoderis K, Florek KR, Patel M, Odle A, Wong LR, Bateman AC, Wang Z, Edara VV, Chong Z, Franks J, Jeevan T, Fabrizio T, DeBeauchamp J, Kercher L, Seiler P, Gonzalez-Reiche AS, Sordillo EM, Chang LA, van Bakel H, Simon V; Consortium Mount Sinai Pathogen Surveillance (PSP) study group; Douek DC, Sullivan NJ, Thackray LB, Ueki H, Yamayoshi S, Imai M, Perlman S, Webby RJ, Seder RA, Suthar MS, García-Sastre A, Schotsaert M, Suzuki T, Boon ACM, Diamond MS, Kawaoka Y., SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters, Nature. 2022 Mar;603(7902):687-692. doi: 10.1038/s41586-022-04441-6. Epub 2022 Jan 21.
Hansen F, Meade-White K, Clancy C, Rosenke R, Okumura A, Hawman DW, Feldmann F, Kaza B, Jarvis MA, Rosenke K, Feldmann H., SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract, Cell Rep. 2022 Mar 15;38(11):110515. doi: 10.1016/j.celrep.2022.110515. Epub 2022 Feb 22.
Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, Walker DH, Plante KS, Menachery VD., SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3, bioRxiv. 2022 Sep 26. pii: 2022.09.26.509529. doi: 10.1101/2022.09.26.509529.
Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, Walker DH, Plante KS, Menachery VD., SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3., J Virol. 2023 Feb 28;97(2):e0153222. doi: 10.1128/jvi.01532-22. Epub 2023 Feb 1.
Plunkard J, Mulka K, Zhou R, Tarwater P, Zhong W, Lowman M, Wong A, Pekosz A, Villano J., SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters., mBio. 2023 Apr 25;14(2):e0007823. doi: 10.1128/mbio.00078-23. Epub 2023 Apr 10.
Hawman DW, Meade-White K, Archer J, Leventhal SS, Wilson D, Shaia C, Randall S, Khandhar AP, Krieger K, Hsiang TY, Gale M, Berglund P, Fuller DH, Feldmann H, Erasmus JH., SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern, Elife. 2022 Feb 22;11. pii: e75537. doi: 10.7554/eLife.75537.
Chan JF, Zhang AJ, Yuan S, et al., Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility., Clin Infect Dis. 2020 Mar 26. pii: ciaa325. doi: 10.1093/cid/ciaa325.
Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJC, Ozorowski G, Li L, Wilbanks GD, Kuroda M, Maemura T, Huang M, Zheng NY, Turner HL, Erickson SA, Fu Y, Yasuhara A, Singh G, Monahan B, Mauldin J, Srivastava K, Simon V, Krammer F, et al., Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants., J Clin Invest. 2023 Apr 17;133(8). pii: e166844. doi: 10.1172/JCI166844.
Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, Kalveram B, Freiberg AN, Menachery VD, Xie X, Plante KS, Weaver SC, Shi PY., Spike mutation D614G alters SARS-CoV-2 fitness, Nature. 2020 Oct 26. doi: 10.1038/s41586-020-2895-3. Online ahead of print.
Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, Kalveram B, Freiberg AN, Menachery VD, Xie X, Plante KS, Weaver SC, Shi PY., Spike mutation D614G alters SARS-CoV-2 fitness., Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26. Erratum in: Nature. 2021 Jul;595(7865):E1.
Ryan KA, Bewley KR, Watson RJ, Burton C, Carnell O, Cavell BE, Challis A, Coombes NS, Davies ER, Edun-Huges J, Emery K, Fell R, Fotheringham SA, Gooch KE, Gowan K, Handley A, Harris DJ, Hesp R, Hunter L, Humphreys R, Johnson R, Kennard C, et al., Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant., PLoS Pathog. 2023 Apr 4;19(4):e1011293. doi: 10.1371/journal.ppat.1011293. eCollection 2023 Apr.
Bednash JS, Kagan VE, Englert JA, Farkas D, Tyurina YY, Tyurin VA, Samovich SN, Farkas L, Elhance A, Johns F, Lee H, Cheng L, Majumdar A, Jones D, Mejia OR, Ruane-Foster M, Londino JD, Mallampalli RK, Robinson RT., Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling, Transl Res. 2022 Feb;240:1-16. doi: 10.1016/j.trsl.2021.10.007. Epub 2021 Nov 2.
Bednash JS, Kagan VE, Englert JA, Farkas D, Tyurina YY, Tyurin VA, Samovich SN, Farkas L, Elhance A, Johns F, Lee H, Cheng L, Majumdar A, Jones D, Mejia OR, Ruane-Foster M, Londino JD, Mallampalli RK, Robinson RT., Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling., Transl Res. 2021 Nov 2. pii: S1931-5244(21)00263-2. doi: 10.1016/j.trsl.2021.10.007. [Epub ahead of print]
Imai M, Iwatsuki-Horimoto K, Hatta M, et al., Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development, Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development [published online ahead of print, 2020 Jun 22]. Proc Natl Acad Sci U S A. 2020;202009799. doi:10.1073/pnas.2009799117
Maio N, Cherry S, Schultz DC, Hurst BL, Linehan WM, Rouault TA., TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model, iScience. 2022 Oct 21;25(10):105074. doi: 10.1016/j.isci.2022.105074. Epub 2022 Sep 6.
Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook MG, Schulz J, Blish CA, Hanson C, Chiu CY, Munster V, Stanley S, Miller CJ., The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters, PLoS Pathog. 2022 Feb 10;18(2):e1009914. doi: 10.1371/journal.ppat.1009914. eCollection 2022 Feb.
Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F., The Development of a Novel Nanobody Therapeutic for SARS-CoV-2, bioRxiv. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. Preprint.
Chan CEZ, Seah SGK, Chye H, Massey S, Torres M, Lim APC, Wong SKK, Neo JJY, Wong PS, Lim JH, Loh GSL, Wang D, Boyd-Kirkup JD, Guan S, Thakkar D, Teo GH, Purushotorman K, Hutchinson PE, Young BE, Low JG, MacAry PA, Hentze H, et al., The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody., PLoS One. 2021 Jun 23;16(6):e0253487. doi: 10.1371/journal.pone.0253487. eCollection 2021.
Stauft CB, Lien CZ, Selvaraj P, Liu S, Wang TT., The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters., Virology. 2021 Apr;556:96-100. doi: 10.1016/j.virol.2021.01.005. Epub 2021 Jan 25.
Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C, Widen SG, Menachery VD, Shi PY, Weaver SC., The N501Y spike substitution enhances SARS-CoV-2 infection and transmission, Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C, Widen SG, Menachery VD, Shi PY, Weaver SC., The N501Y spike substitution enhances SARS-CoV-2 infection and transmission., Nature. 2021 Nov 24. doi: 10.1038/s41586-021-04245-0. [Epub ahead of print]
Davies ER, Ryan KA, Bewley KR, Coombes NS, Salguero FJ, Carnell OT, Biddlecombe S, Charlton M, Challis A, Cross ES, Handley A, Ngabo D, Weldon TM, Hall Y, Funnell SGP., The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection., Viruses. 2023 May 10;15(5). pii: 1133. doi: 10.3390/v15051133.
Arieta CM, Xie YJ, Rothenberg DA, Diao H, Harjanto D, Meda S, Marquart K, Koenitzer B, Sciuto TE, Lobo A, Zuiani A, Krumm SA, Cadima Couto CI, Hein S, Heinen AP, Ziegenhals T, Liu-Lupo Y, Vogel AB, Srouji JR, Fesser S, Thanki K, Walzer K, et al., The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection., Cell. 2023 May 25;186(11):2392-2409.e21. doi: 10.1016/j.cell.2023.04.007. Epub 2023 Apr 13.
Halfmann PJ, Uraki R, Kuroda M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Kawaoka Y., Transmission and re-infection of Omicron variant XBB.1.5 in hamsters., EBioMedicine. 2023 Jul;93:104677. doi: 10.1016/j.ebiom.2023.104677. Epub 2023 Jun 21.
Knott D, Fell R, Potter JA, Yuille S, Salguero FJ, Graham VA, Hewson R, Howat D, Dowall SD., Use of a Preclinical Natural Transmission Model to Study Antiviral Effects of a Carbohydrate-Binding Module Therapy against SARS-CoV-2 in Hamsters., Viruses. 2023 Mar 11;15(3). pii: 725. doi: 10.3390/v15030725.
Blanas A, Karsjens H, de Ligt A, Huijbers EJM, van Loon K, Denisov SS, Durukan C, Engbersen DJM, Groen J, Hennig S, Hackeng TM, van Beijnum JR, Griffioen AW., Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19, iScience. 2022 Aug 19;25(8):104719. doi: 10.1016/j.isci.2022.104719. Epub 2022 Jul 5.
Ebenig A, Muraleedharan S, Kazmierski J, Todt D, Auste A, Anzaghe M, Gömer A, Postmus D, Gogesch P, Niles M, Plesker R, Miskey C, Gellhorn Serra M, Breithaupt A, Hörner C, Kruip C, Ehmann R, Ivics Z, Waibler Z, Pfaender S, Wyler E, Landthaler M, Kupke A, Nouailles G, Goffinet C, Brown RJP, Mühlebach MD., Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after T(H)2-biased immunization, Cell Rep. 2022 Aug 16;40(7):111214. doi: 10.1016/j.celrep.2022.111214. Epub 2022 Aug 3.
Ellison, T. J., Talbott, G. C., & Henderson, D. R., VaxiPatchâ˘, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017, Vaccine 38, no. 43 (2020): 6839-6848.
Arora J, Patel DR, Nicol MJ, Field CJ, Restori KH, Wang J, Froelich NE, Katkere B, Terwilliger JA, Weaver V, Luley E, Kelly K, Kirimanjeswara GS, Sutton TC, Cantorna MT., Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs, Nutrients. 2022 Jul 26;14(15). pii: 3061. doi: 10.3390/nu14153061.
Forero C, Ritter JM, Seixas JN, Coleman-McCray JD, Brake M, Condrey JA, Tansey C, Welch SR, Genzer SC, Spengler JR., Volume-Associated Clinical and Histopathological Effects of Intranasal Instillation in Syrian Hamsters: Considerations for Infection and Therapeutic Studies, Pathogens. 2022 Aug 10;11(8). pii: 898. doi: 10.3390/pathogens11080898.
O'Donnell KL, Gourdine T, Fletcher P, Shifflett K, Furuyama W, Clancy CS, Marzi A., VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern, Vaccines (Basel). 2022 Mar 12;10(3). pii: 435. doi: 10.3390/vaccines10030435.
General studies
Dalboge, L. S., Pedersen, P. J., Hansen, G., Fabricius, K., Hansen, H. B., Jelsing, J., & Vrang, N. (2015), A hamster model of diet-induced obesity for preclinical evaluation of anti-obesity, anti-diabetic and lipid modulating agents. PloS, PloS One, 10(8), e0135634. doi:10.1371/journal.pone.0135634 [doi]
Shannonhouse, J. L., Urbanski, H. F., Woo, S. L., Fong, L. A., Goddard, S. D., Lucas, W. F., . . . Morgan, C. (2014)., Aquaporin-11 control of testicular fertility markers in syrian hamsters., Molecular and Cellular Endocrinology, 391(1-2), 1-9. doi:10.1016/j.mce.2014.04.011 [doi]
Stephens, A. M., & Sanders, T. H. (2015)., Blood lipid distribution, aortic cholesterol concentrations, and selected inflammatory and bile metabolism markers in syrian hamsters fed a standard breeding diet, Journal of the American Association for Laboratory Animal Science : JAALAS, 54(4), 353-358.
Khokhar, J. Y., Chau, D. T., Dawson, R., & Green, A. I. (2015)., Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan, Drug and Alcohol Dependence, 152, 277-281. doi:10.1016/j.drugalcdep.2015.04.003 [doi]
Chau, D. T., Khokhar, J. Y., Gulick, D., Dawson, R., & Green, A. I. (2015)., Desipramine enhances the ability of paliperidone to decrease alcohol drinking, Journal of Psychiatric Research, 69, 9-18. doi:10.1016/j.jpsychires.2015.07.010 [doi]
Khokhar, J. Y., & Green, A. I. (2016)., Effects of iloperidone, combined with desipramine, on alcohol drinking in the syrian golden hamster., Neuropharmacology, 105, 25-34. doi:S0028-3908(16)30017-X [pii]
Schenk, G. J., Haasnoot, P. C., Centlivre, M., Legrand, N., Rip, J., de Boer, A. G., & Berkhout, B. (2012)., Efficient CRM197-mediated drug targeting to monocytes. Journal of Controlled Release, Official Journal of the Controlled Release Society, 158(1), 139-147. doi:10.1016/j.jconrel.2011.09.091 [doi]
Prendergast, B. J., Beery, A. K., Paul, M. J., & Zucker, I. (2012)., Enhancement and suppression of ultradian and circadian rhythms across the female hamster reproductive cycle., Journal of Biological Rhythms, 27(3), 246-256. doi:10.1177/0748730412441315 [doi]
Dong, B., Singh, A. B., Shende, V. R., & Liu, J. (2017)., Hepatic HNF1 transcription factors control the induction of PCSK9 mediated by rosuvastatin in normolipidemic hamsters., International Journal of Molecular Medicine, 39(3), 749-756. doi:10.3892/ijmm.2017.2879 [doi]
Dong, B., Singh, A. B., Azhar, S., Seidah, N. G., & Liu, J. (2015)., High-fructose feeding promotes accelerated degradation of hepatic LDL receptor and hypercholesterolemia in hamsters via elevated circulating PCSK9 levels., Atherosclerosis, 239(2), 364-374. doi:10.1016/j.atherosclerosis.2015.01.013 [doi]
Schlenker, E. H., Del Rio, R., & Schultz, H. D. (2015)., In adult female hamsters hypothyroidism stimulates D1 receptor-mediated breathing without altering D1 receptor expression., Respiratory Physiology & Neurobiology, 218, 32-39. doi:10.1016/j.resp.2015.07.011 [doi]
Li M, van Raath MI, Khakpour S, Seçilir A, Sliggers BC, Huang X, Ding B, Storm G, van der Hulst RR, de Kroon AIPM, Heger M., In Vivo Assessment of Thermosensitive Liposomes for the Treatment of Port Wine Stains by Antifibrinolytic Site-Specific Pharmaco-Laser Therapy, Pharmaceutics. 2020 Jun 25;12(6):591. doi: 10.3390/pharmaceutics12060591.
Dugbartey, G. J., Bouma, H. R., Strijkstra, A. M., Boerema, A. S., & Henning, R. H. (2015)., Induction of a torpor-like state by 5'-AMP does not depend on H2S production, PloS One, 10(8), e0136113. doi:10.1371/journal.pone.0136113 [doi]
Liu, J., Iqbal, A., Raslawsky, A., Browne, R. W., Patel, M. S., & Rideout, T. C. (2016)., Influence of maternal hypercholesterolemia and phytosterol intervention during gestation and lactation on dyslipidemia and hepatic lipid metabolism in offspring of syrian golden hamsters., Molecular Nutrition & Food Research, 60(10), 2151-2160. doi:10.1002/mnfr.201600116 [doi]
Shah, V. D., Walton, B. J., Culp, A. G., & Castellino, S. (2015)., Investigation of blue bedding in cages housing treatment-naive hamsters., Journal of the American Association for Laboratory Animal Science : JAALAS, 54(6), 799-802.
Soref, C. M., & Fahl, W. E. (2015)., Optimum topical delivery of adrenergic agonists to oral mucosa vasculature, Pharmaceutical Research, 32(2), 492-499. doi:10.1007/s11095-014-1477-1 [doi]
Kan, C. F., Singh, A. B., Dong, B., Shende, V. R., & Liu, J. (2015), PPARdelta activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro., Biochimica Et Biophysica Acta, 1851(5), 577-587. doi:10.1016/j.bbalip.2015.01.008 [doi]
Gerrits, P. O., Kortekaas, R., Veening, J. G., de Weerd, H., & van der Want, J. J. (2012)., Reduced aging defects in estrogen receptive brainstem nuclei in the female hamster., Neurobiology of Aging, 33(12), 2920-2934. doi:10.1016/j.neurobiolaging.2012.02.018 [doi]
Gerrits, P. O., Kortekaas, R., de Weerd, H., Veening, J. G., & van der Want, J. J. (2012), Regional differences in age-related lipofuscin accumulation in the female hamster brainstem, Neurobiology of Aging, 33(3), 625.e1-625.e9. doi:10.1016/j.neurobiolaging.2011.03.015 [doi]
Dong, B., Young, M., Liu, X., Singh, A. B., & Liu, J. (2017)., Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters, Journal of Lipid Research, 58(2), 350-363. doi:10.1194/jlr.M070888 [doi]
Gerrits, P. O., Kortekaas, R., de Weerd, H., Luiten, P. G., van der Want, J. J., & Veening, J. G. (2013)., Spumiform basement membrane aberrations in the microvasculature of the midbrain periaqueductal gray region in hamster: Rostro-caudal pathogenesis?, Neuroscience, 228, 128-138. doi:10.1016/j.neuroscience.2012.10.021 [doi]
Gerrits, P. O., Kortekaas, R., de Weerd, H., Veenstra-Algra, A., Luiten, P. G., van der Want, J. J., & Veening, J. G. (2013)., Spumiform capillary basement membrane swelling: A new type of microvascular degeneration in senescent hamster, Neurobiology of Aging, 34(4), 1277-1286. doi:10.1016/j.neurobiolaging.2012.09.009 [doi]
Piekarski, D. J., Seto, T., & Zucker, I. (2012)., The protein synthesis inhibitor anisomycin reduces sex behavior during a critical period after testosterone treatment in male syrian hamsters., Physiology & Behavior, 105(2), 215-219. doi:10.1016/j.physbeh.2011.08.025 [doi]
Brague, J. C., Zinn, C. R., Granot, D. Y., Feathers, C. T., & Swann, J. M. (2018), TrkB is necessary for male copulatory behavior in the syrian hamster (mesocricetus auratus)., Hormones and Behavior, 97, 162-169. doi:S0018-506X(17)30241-6 [pii]
Infectious disease
Ejemel M, Smith TG, Greenberg L, Carson WC, Lowe D, Yang Y, Jackson FR, Morgan CN, Martin BE, Kling C, Hutson CL, Gallardo-Romero N, Ellison JA, Moore S, Buzby A, Sullivan-Bolyai J, Klempner M, Wang Y., A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis, Sci Rep. 2022 Jun 7;12(1):9403. doi: 10.1038/s41598-022-13527-0.
Noon, Jason B; Schwarz, Erich M; Ostroff, Gary R; Aroian, Raffi V;, A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection., PLoS neglected tropical diseases Vol.13, 2019
Wunder EA, Adhikarla H, Hamond C, Owers Bonner KA, Liang L, Rodrigues CB, Bisht V, Nally JE, Alt DP, Reis MG, Diggle PJ, Felgner PL, Ko A., A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus., Elife. 2021 Jan 26;10. pii: e64166. doi: 10.7554/eLife.64166.
Roberts AK, Harris HC, Smith M, Giles J, Polak O, Buckley AM, Clark E, Ewin D, Moura IB, Spitall W, Shone CC, Wilcox M, Chilton C, Donev R., A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models, Front Microbiol. 2020 Sep 22;11:578903. doi: 10.3389/fmicb.2020.578903. eCollection 2020.
Anguiano-Zarate, S. S., Matchett, W. E., Nehete, P., Sastry, K. J., Marzi, A., & Barry, M. A. (2018)., A replicating single-cycle adenovirus vaccine against ebola virus., The Journal of Infectious Diseases, doi:10.1093/infdis/jiy411 [doi]
Matchett WE, Anguiano-Zarate S, Malewana GBR, Mudrick H, Weldy M, Evert C, Khoruts A, Sadowsky M, Barry MA., A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile, Vaccines (Basel). 2020 Aug 22;8(3):470. doi: 10.3390/vaccines8030470.
van Doremalen, Neeltje; Lambe, Teresa; Sebastian, Sarah; Bushmaker, Trenton; Fischer, Robert; Feldmann, Friederike; Haddock, Elaine; Letko, Michael; Avanzato, Victoria A; Rissanen, Ilona; LaCasse, Rachel; Scott, Dana; Bowden, Thomas A; Gilbert, Sarah; Munster, Vincent;, A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters., PLoS neglected tropical diseases Vol.13, 2019
Nistal-Villan, E., Poutou, J., Rodriguez-Garcia, E., Bunuales, M., Carte-Abad, B., Prieto, J., . . . Larrea, E. (2016), A versatile vector for in vivo monitoring of type I interferon induction and signaling., PloS One, 11(3), e0152031. doi:10.1371/journal.pone.0152031 [doi]
Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE, Nekorchuk M, Busman-Sahay K, Piedra-Mora C, Wrijil LM, Ducat S, Custers J, Atyeo C, Fischinger S, Burke JS, Feldman J, Hauser BM, Caradonna TM, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Lin Z, Mahrokhian SH, Nampanya F, Nityanandam R, Pessaint L, Porto M, Ali V, Benetiene D, Tevi K, Andersen H, Lewis MG, Schmidt AG, Lauffenburger DA, Alter G, Estes JD, Schuitemaker H, Zahn R, Barouch DH., Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters, Nat Med. 2020 Nov;26(11):1694-1700. doi: 10.1038/s41591-020-1070-6. Epub 2020 Sep 3.
Radke JR, Covert HJ, Bauer F, Ananthanarayanan V, Cook JL., Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster, Viruses. 2020 May 30;12(6):595. doi: 10.3390/v12060595.
Montes-Galindo, Daniel A; Espiritu-Mojarro, Ana C; Melnikov, Valery; Moy-LĂłpez, Norma A; Soriano-Hernandez, Alejandro D; Galvan-Salazar, Hector R; Guzman-MuĂąiz, Jorge; Guzman-Esquivel, Jose; Martinez-Fierro, Margarita L; Rodriguez-Sanchez, Iram P; Paz-Michel, Brenda; Zaizar-Fregoso, Sergio A; Sanchez-Ramirez, Carmen A; Ramirez-Flores, Mario; Delgado-Enciso, Ivan, Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters., Archives of virology Vol.164, 2019
Genzer SC, Welch SR, Scholte FEM, Harmon JR, Coleman-McCray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR., Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model, J Infect Dis. 2020 May 11;221(Supplement_4):S454-S459. doi: 10.1093/infdis/jiz552.
Genzer, Sarah C; Welch, Stephen R; Scholte, Florine E M; Harmon, Jessica R; Coleman-McCray, JoAnn D; Lo, Michael K; Montgomery, Joel M; Nichol, Stuart T; Spiropoulou, Christina F; Spengler, Jessica R;, Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model., Journal of infectious diseases Vol., 2019
Li H, Gazzola D, Hu Y, Aroian RV., An efficient method for viable cryopreservation and recovery of hookworms and other gastrointestinal nematodes in the laboratory., Int J Parasitol. 2023 Jul;53(8):451-458. doi: 10.1016/j.ijpara.2023.05.001. Epub 2023 May 16.
Yuen CK, Wong WM, Mak LF, Lam JY, Cheung LY, Cheung DT, Ng YY, Lee AC, Zhong N, Yuen KY, Kok KH., An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models., Nat Commun. 2023 Oct 24;14(1):6762. doi: 10.1038/s41467-023-42349-5.
Gretebeck LM, Subbarao K., Animal models for SARS and MERS coronaviruses., Curr Opin Virol. 2015 Aug;13:123-9. doi: 10.1016/j.coviro.2015.06.009. Epub 2015 Jul 14.
Schaar, K., Geisler, A., Kraus, M., Pinkert, S., Pryshliak, M., Spencer, J. F., . . . Fechner, H. (2017)., Anti-adenoviral artificial MicroRNAs expressed from AAV9 vectors inhibit human adenovirus infection in immunosuppressed syrian hamsters, Molecular Therapy.Nucleic Acids, 8, 300-316. doi:S2162-2531(17)30212-3 [pii]
Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Maison RM, Gazumyan A, Martinez DR, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Bowen RA, Nussenzweig MC, Sheahan TP., Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo, J Exp Med. 2021 Mar 1;218(3):e20201993. doi: 10.1084/jem.20201993.
Engdahl TB, Binshtein E, Brocato RL, Kuzmina NA, Principe LM, Kwilas SA, Kim RK, Chapman NS, Porter MS, Guardado-Calvo P, Rey FA, Handal LS, Diaz SM, Zagol-Ikapitte IA, Tran MH, McDonald WH, Meiler J, Reidy JX, Trivette A, Bukreyev A, Hooper JW, Crowe JE., Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies., Elife. 2023 Mar 27;12. pii: e81743. doi: 10.7554/eLife.81743.
Perley CC, Brocato RL, Wu H, Bausch C, Karmali PP, Vega JB, Cohen MV, Somerville B, Kwilas SA, Principe LM, Shamblin J, Chivukula P, Sullivan E, Hooper JW., Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models, Front Microbiol. 2020 May 7;11:832. doi: 10.3389/fmicb.2020.00832. eCollection 2020.
Peniche, A. G., Renslo, A. R., Melby, P. C., & Travi, B. L. (2015)., Antileishmanial activity of disulfiram and thiuram disulfide analogs in an ex vivo model system is selectively enhanced by the addition of divalent metal ions, Antimicrobial Agents and Chemotherapy, 59(10), 6463-6470. doi:10.1128/AAC.05131-14 [doi]
Miret JA, Moreno J, Nieto J, Carter KC, Mullen AB, Ambros L, Rodríguez C, San Andrés MI, González F., Antileishmanial efficacy and tolerability of combined treatment with non-ionic surfactant vesicle formulations of sodium stibogluconate and paromomycin in dogs, Exp Parasitol. 2021 Jan;220:108033. doi: 10.1016/j.exppara.2020.108033. Epub 2020 Nov 7.
Cortez LM, Nemani SK, Duque VelĂĄsquez C, Sriraman A, Wang Y, Wille H, McKenzie D, Sim VL., Asymmetric-flow field-flow fractionation of prions reveals a strain-specific continuum of quaternary structures with protease resistance developing at a hydrodynamic radius of 15 nm., PLoS Pathog. 2021 Jun 28;17(6):e1009703. doi: 10.1371/journal.ppat.1009703. eCollection 2021 Jun.
Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Kawaoka Y, Kane RS., Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine., Res Sq. 2023 Jun 29. pii: rs.3.rs-3088907. doi: 10.21203/rs.3.rs-3088907/v1.
Rees, J., Haig, D., Mack, V., & Davis, W. C. (2017)., Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules, Veterinary Immunology and Immunopathology, 183, 40-44. doi:S0165-2427(16)30346-4 [pii]
Scholte FEM, Rodriguez SE, Welch SR, Davies KA, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Lo MK, Karaaslan E, Bergeron E, Montgomery JM, Spengler JR, Spiropoulou CF., Characterization of humoral responses to Nipah virus infection in the Syrian Hamster model of disease., J Infect Dis. 2023 Dec 8. pii: jiad557. doi: 10.1093/infdis/jiad557. [Epub ahead of print]
Tian, J. H., Glenn, G., Flyer, D., Zhou, B., Liu, Y., Sullivan, E., . . . Smith, G. (2017)., Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models., Vaccine, 35(33), 4079-4087. doi:S0264-410X(17)30859-9 [pii]
Bungiro RD, Harrison LM, Dondji B, Cappello M., Comparison of percutaneous vs oral infection of hamsters with the hookworm Ancylostoma ceylanicum: Parasite development, pathology and primary immune response, PLoS Negl Trop Dis. 2022 Jan 5;16(1):e0010098. doi: 10.1371/journal.pntd.0010098. eCollection 2022 Jan.
Brocato RL, Altamura LA, Carey BD, Perley CC, Blancett CD, Minogue TD, Hooper JW., Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString., PLoS Negl Trop Dis. 2021 Aug 2;15(8):e0009592. doi: 10.1371/journal.pntd.0009592. eCollection 2021 Aug.
Doyle MP, Kose N, Borisevich V, Binshtein E, Amaya M, Nagel M, Annand EJ, Armstrong E, Bombardi R, Dong J, Schey KL, Broder CC, Zeitlin L, Kuang EA, Bornholdt ZA, West BR, Geisbert TW, Cross RW, Crowe JE Jr., Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein., Cell Rep. 2021 Aug 31;36(9):109628. doi: 10.1016/j.celrep.2021.109628.
Welch SR, Spengler JR, Harmon JR, Coleman-McCray JD, Scholte FEM, Genzer SC, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF., Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease, mBio. 2022 Apr 26;13(2):e0329421. doi: 10.1128/mbio.03294-21. Epub 2022 Mar 17.
Rosenke K, Meade-White K, Letko M, Clancy C, Hansen F, Liu Y, Okumura A, Tang-Huau TL, Li R, Saturday G, Feldmann F, Scott D, Wang Z, Munster V, Jarvis MA, Feldmann H., Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection, Emerg Microbes Infect. 2020 Nov 29:1-36. doi: 10.1080/22221751.2020.1858177. Online ahead of print.
Hammerbeck, C. D., Brocato, R. L., Bell, T. M., Schellhase, C. W., Mraz, S. R., Queen, L. A., & Hooper, J. W. (2016)., Depletion of alveolar macrophages does not prevent hantavirus disease pathogenesis in golden syrian hamsters., Journal of Virology, 90(14), 6200-6215. doi:10.1128/JVI.00304-16 [doi]
Jain S, Lo MK, Kainulainen MH, Welch SR, Spengler JR, Satter SM, Rahman MZ, Hossain ME, Chiang CF, Klena JD, Bergeron É, Montgomery JM, Spiropoulou CF, Albariño CG., Development of a neutralization assay using a vesicular stomatitis virus expressing Nipah virus glycoprotein and a fluorescent protein., Virology. 2023 Oct;587:109858. doi: 10.1016/j.virol.2023.109858. Epub 2023 Aug 2.
Clubb JHA, Kudling TV, Girych M, Haybout L, Pakola S, Hamdan F, Cervera-Carrascon V, Hemmes A, Grönberg-Vähä-Koskela S, Santos JM, Quixabeira DCA, Basnet S, Heiniö C, Arias V, Jirovec E, Kaptan S, Havunen R, Sorsa S, Erikat A, Schwartz J, Anttila M, Aro K, et al., Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting., Front Immunol. 2023 Feb 3;14:1060540. doi: 10.3389/fimmu.2023.1060540. eCollection 2023.
Wilson, M., Glaser, K. C., Adams-Fish, D., Boley, M., Mayda, M., & Molestina, R. E. (2015)., Development of droplet digital PCR for the detection of babesia microti and babesia duncani, Experimental Parasitology, 149, 24-31. doi:10.1016/j.exppara.2014.12.003 [doi]
Wilson, M., Glaser, K. C., Adams-Fish, D., Boley, M., Mayda, M., & Molestina, R. E. (2015)., Development of droplet digital PCR for the detection of babesia microti and babesia duncani., Experimental Parasitology, 149, 24-31. doi:10.1016/j.exppara.2014.12.003 [doi]
Pritzkow, S., Morales, R., Lyon, A., Concha-Marambio, L., Urayama, A., & Soto, C. (2018)., Efficient prion disease transmission through common environmental materials., The Journal of Biological Chemistry, 293(9), 3363-3373. doi:10.1074/jbc.M117.810747 [doi]
Ferreira WT, Hong HA, Adams JRG, Hess M, Kotowicz NK, Tan S, Ferrari E, Brisson A, Zentek J, Soloviev M, Cutting SM., Environmentally Acquired Bacillus and Their Role in C. difficile Colonization Resistance, Biomedicines. 2022 Apr 19;10(5). pii: 930. doi: 10.3390/biomedicines10050930.
Vitucci JC, Pulse M, Tabor-Simecka L, Simecka J., Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models, BMC Microbiol. 2020 Feb 5;20(1):27. doi: 10.1186/s12866-020-1710-5.
Findlay-Wilson S, Flett L, Salguero FJ, Ruedas-Torres I, Fotheringham S, Easterbrook L, Graham V, Dowall S., Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge., Pathogens. 2023 Jul 26;12(8). pii: 976. doi: 10.3390/pathogens12080976.
Bilbao-Ramos P, Serrano DR, Ruiz Saldaña HK, Torrado JJ, Bolás-Fernández F, Dea-Ayuela MA., Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis, Molecules. 2020 Mar 19;25(6):1394. doi: 10.3390/molecules25061394.
Lo MK, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Scholte FEM, Shrivastava-Ranjan P, Montgomery JM, Nichol ST, Weissman D, Spiropoulou CF., Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters, J Infect Dis. 2020 May 11;221(Supplement_4):S493-S498. doi: 10.1093/infdis/jiz553.
Magni R, Almofee R, Yusuf S, Mueller C, Vuong N, Almosuli M, Hoang MT, Meade K, Sethi I, Mohammed N, Araujo R, McDonald TK, Marcelli P, Espina V, Kim B, Garritsen A, Green C, Russo P, Zhou W, Vaisman I, Petricoin EF 3rd, Hoadley D, Molestina RE, McIntyre H, Liotta LA, Luchini A., Evaluation of pathogen specific urinary peptides in tick-borne illnesses, Sci Rep. 2020 Nov 9;10(1):19340. doi: 10.1038/s41598-020-75051-3.
Hsieh, C. L., Ptak, C. P., Tseng, A., Suguiura, I. M. S., McDonough, S. P., Sritrakul, T., . . . Chang, Y. F. (2017)., Extended low-resolution structure of a leptospira antigen offers high bactericidal antibody accessibility amenable to vaccine design., Elife, 6, 10.7554/eLife.30051. doi:10.7554/eLife.30051 [doi]
Lewis MD, Paun A, Romano A, Langston H, Langner CA, Moore IN, Bock KW, Francisco AF, Brenchley JM, Sacks DL., Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis, PLoS Pathog. 2020 Apr 13;16(4):e1008456. doi: 10.1371/journal.ppat.1008456. eCollection 2020 Apr.
Johnson BA, Xie X, Kalveram B, Lokugamage KG, Muruato A, Zou J, Zhang X, Juelich T, Smith JK, Zhang L, Bopp N, Schindewolf C, Vu M, Vanderheiden A, Swetnam D, Plante JA, Aguilar P, Plante KS, Lee B, Weaver SC, Suthar MS, Routh AL, Ren P, Ku Z, An Z, Debbink K, Shi PY, Freiberg AN, Menachery VD., Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis, bioRxiv. 2020 Aug 26:2020.08.26.268854. doi: 10.1101/2020.08.26.268854. Preprint.
Witkowski, P. T., Perley, C. C., Brocato, R. L., Hooper, J. W., Jurgensen, C., Schulzke, J. D., . . . Bucker, R. (2017)., Gastrointestinal tract as entry route for hantavirus infection, Frontiers in Microbiology, 8, 1721. doi:10.3389/fmicb.2017.01721 [doi]
Parviainen, S., Ahonen, M., Diaconu, I., Kipar, A., Siurala, M., Vaha-Koskela, M., . . . Hemminki, A. (2015), GMCSF-armed vaccinia virus induces an antitumor immune response, International Journal of Cancer, 136(5), 1065-1072. doi:10.1002/ijc.29068 [doi]
Pritzkow, S., Morales, R., Moda, F., Khan, U., Telling, G. C., Hoover, E., & Soto, C. (2015)., Grass plants bind, retain, uptake, and transport infectious prions., Cell Reports, 11(8), 1168-1175. doi:10.1016/j.celrep.2015.04.036 [doi]
Lo MK, Spengler JR, Krumpe LRH, Welch SR, Chattopadhyay A, Harmon JR, Coleman-McCray JD, Scholte FEM, Hotard AL, Fuqua JL, Rose JK, Nichol ST, Palmer KE, O'Keefe BR, Spiropoulou CF., Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge, J Infect Dis. 2020 May 11;221(Supplement_4):S480-S492. doi: 10.1093/infdis/jiz630.
Toth, K., Spencer, J. F., Ying, B., Tollefson, A. E., & Wold, W. S. M. (2017)., HAdV-C6 is a more relevant challenge virus than HAdV-C5 for testing antiviral drugs with the immunosuppressed syrian hamster model., Viruses, 9(6), 10.3390/v9060147. doi:E147 [pii]
Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., ... & Cornelius, A., Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates, bioRxiv. 2020. November 20, 2020. doi: https://doi.org/10.1101/2020.08.25.256339
Kraus A, Hoyt F, Schwartz CL, Hansen B, Artikis E, Hughson AG, Raymond GJ, Race B, Baron GS, Caughey B., High-resolution structure and strain comparison of infectious mammalian prions., Mol Cell. 2021 Nov 4;81(21):4540-4551.e6. doi: 10.1016/j.molcel.2021.08.011. Epub 2021 Aug 25.
Crowell, J., Hughson, A., Caughey, B., & Bessen, R. A. (2015)., Host determinants of prion strain diversity independent of prion protein genotype., Journal of Virology, 89(20), 10427-10441. doi:10.1128/JVI.01586-15 [doi]
Hou YJ, Chiba S, Leist SR, Meganck RM, Martinez DR, Schäfer A, Catanzaro NJ, Sontake V, West A, Edwards CE, Yount B, Lee RE, Gallant SC, Zost SJ, Powers J, Adams L, Kong EF, Mattocks M, Tata A, Randell SH, Tata PR, Halfmann P, et al., Host range, transmissibility and antigenicity of a pangolin coronavirus., Nat Microbiol. 2023 Oct;8(10):1820-1833. doi: 10.1038/s41564-023-01476-x. Epub 2023 Sep 25.
Mittler E, Wec AZ, Tynell J, Guardado-Calvo P, Wigren-Byström J, Polanco LC, O'Brien CM, Slough MM, Abelson DM, Serris A, Sakharkar M, Pehau-Arnaudet G, Bakken RR, Geoghegan JC, Jangra RK, Keller M, Zeitlin L, Vapalahti O, Ulrich RG, Bornholdt ZA, Ahlm C, Rey FA, Dye JM, Bradfute SB, Strandin T, Herbert AS, Forsell MNE, Walker LM, Chandran K., Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses, Sci Transl Med. 2022 Mar 16;14(636):eabl5399. doi: 10.1126/scitranslmed.abl5399. Epub 2022 Mar 16.
Liu X, Liang B, Liu X, Amaro-Carambot E, Surman S, Kwong PD, Graham BS, Collins PL, Munir S., Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates, PLoS One. 2020 Feb 11;15(2):e0228572. doi: 10.1371/journal.pone.0228572. eCollection 2020.
Baseler, L., Scott, D. P., Saturday, G., Horne, E., Rosenke, R., Thomas, T., . . . de Wit, E. (2016), Identifying early target cells of nipah virus infection in syrian hamsters., PLoS Neglected Tropical Diseases, 10(11), e0005120. doi:10.1371/journal.pntd.0005120 [doi]
Elder, A. M., Henderson, D. M., Nalls, A. V., Hoover, E. A., Kincaid, A. E., Bartz, J. C., & Mathiason, C. K. (2015), Immediate and ongoing detection of prions in the blood of hamsters and deer following oral, nasal, or blood inoculations. Journal, Journal of Virology, 89(14), 7421-7424. doi:JVI.00760-15 [pii]
Groseth A, Gardner D, Meade-White K, Amler S, Ebihara H., Immunocompetent hamsters as a model for orthobunyavirus-induced neuroinvasion and neuropathology., PLoS Negl Trop Dis. 2023 May 26;17(5):e0011355. doi: 10.1371/journal.pntd.0011355. eCollection 2023 May.
Ghose, C., Eugenis, I., Edwards, A. N., Sun, X., McBride, S. M., & Ho, D. D. (2016), Immunogenicity and protective efficacy of clostridium difficile spore proteins., Anaerobe, 37, 85-95. doi:10.1016/j.anaerobe.2015.12.001 [doi]
Ghose, C., Eugenis, I., Sun, X., Edwards, A. N., McBride, S. M., Pride, D. T., . . . Ho, D. D. (2016)., Immunogenicity and protective efficacy of recombinant clostridium difficile flagellar protein FliC., Emerging Microbes & Infections, 5, e8. doi:10.1038/emi.2016.8 [doi]
Evangelista, K. V., Lourdault, K., Matsunaga, J., & Haake, D. A. (2017)., Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis., PloS One, 12(7), e0180004. doi:10.1371/journal.pone.0180004 [doi]
Welch SR, Scholte FEM, Harmon JR, Coleman-McCray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR., In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model, J Infect Dis. 2020 May 11;221(Supplement_4):S448-S453. doi: 10.1093/infdis/jiz393.
Welch, Stephen R; Scholte, Florine E M; Harmon, Jessica R; Coleman-McCray, JoAnn D; Lo, Michael K; Montgomery, Joel M; Nichol, Stuart T; Spiropoulou, Christina F; Spengler, Jessica R;, In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model., The Journal of infectious diseases Vol.13, 2019
Kurup, Drishya; Fisher, Christine R; Smith, Todd G; Abreu-Mota, Tiago; Yang, Yong; Jackson, Felix R; Gallardo-Romero, Nadia; Franka, Richard; Bronshtein, Victor; Schnell, Matthias J;, Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge., The Journal of infectious diseases Vol.220, 2019
Langenfeld, K. A., Shikiya, R. A., Kincaid, A. E., & Bartz, J. C. (2016)., Incongruity between prion conversion and incubation period following coinfection., Journal of Virology, 90(12), 5715-5723. doi:10.1128/JVI.00409-16 [doi]
Sherman TJ, Petty D, Schountz T, Hodges N, Hawkinson AC., Increased Ifng and Il10 Expression Correlate with Disease in Rodent Models Experimentally Infected with Modoc Virus, Viruses. 2022 May 11;14(5). pii: 1026. doi: 10.3390/v14051026.
Paterson J, Ryan KA, Morley D, Jones NJ, Yeates P, Hall Y, Whittaker CJ, Salguero FJ, Marriott AC., Infection with Seasonal H1N1 Influenza Results in Comparable Disease Kinetics and Host Immune Responses in Ferrets and Golden Syrian Hamsters., Pathogens. 2023 Apr 30;12(5). pii: 668. doi: 10.3390/pathogens12050668.
Carlsen, E. D., Jie, Z., Liang, Y., Henard, C. A., Hay, C., Sun, J., . . . Soong, L. (2015)., Interactions between neutrophils and leishmania braziliensis amastigotes facilitate cell activation and parasite clearance., Journal of Innate Immunity, 7(4), 354-363. doi:10.1159/000373923 [doi]
Shinoda S, Sharma NS, Nakamura N, Inoko K, Sato-Dahlman M, Murugan P, Davydova J, Yamamoto M., Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model, Cancer Sci. 2023 Sep;114(9):3759-3769. doi: 10.1111/cas.15903. Epub 2023 Jul 13.
Hornsby RL, Alt DP, Nally JE., Isolation and propagation of leptospires at 37 °C directly from the mammalian host, Sci Rep. 2020 Jun 15;10(1):9620. doi: 10.1038/s41598-020-66526-4.
Falzarano, D., Safronetz, D., Prescott, J., Marzi, A., Feldmann, F., & Feldmann, H. (2015)., Lack of protection against ebola virus from chloroquine in mice and hamsters., Emerging Infectious Diseases, 21(6), 1065-1067. doi:10.3201/eid2106.150176 [doi]
Serafim TD, Iniguez E, Barletta ABF, Cecilio P, Doehl JSP, Short M, Lack J, Nair V, Disotuar M, Wilson T, Coutinho-Abreu IV, Meneses C, Andersen J, Alves E Silva TL, Oliveira F, Vega-Rodriguez J, Barillas-Mury C, Ribeiro JMC, Beverley SM, Kamhawi S, Valenzuela JG., Leishmania genetic exchange is mediated by IgM natural antibodies., Nature. 2023 Nov;623(7985):149-156. doi: 10.1038/s41586-023-06655-8. Epub 2023 Oct 25.
Arango Duque, G., Fukuda, M., Turco, S. J., Stager, S., & Descoteaux, A. (2014), Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI., Journal of Immunology (Baltimore, Md.: 1950), 193(5), 2363-2372. doi:10.4049/jimmunol.1303043 [doi]
Kuipers ME, Nguyen DL, van Diepen A, Mes L, Bos E, Koning RI, Nolte-'t Hoen ENM, Smits HH, Hokke CH., Life stage-specific glycosylation of extracellular vesicles from Schistosoma mansoni schistosomula and adult worms drives differential interaction with C-type lectin receptors DC-SIGN and MGL., Front Mol Biosci. 2023 Mar 15;10:1125438. doi: 10.3389/fmolb.2023.1125438. eCollection 2023.
Radke, J. R., Yong, S. L., & Cook, J. L. (2015), Low-level expression of the E1B 20-kilodalton protein by adenovirus 14p1 enhances viral immunopathogenesis, Journal of Virology, 90(1), 497-505. doi:10.1128/JVI.01790-15 [doi]
Hu, Y., Zhan, B., Keegan, B., Yiu, Y. Y., Miller, M. M., Jones, K., & Aroian, R. V. (2012)., Mechanistic and single-dose in vivo therapeutic studies of Cry5B anthelmintic action against hookworms., PLoS Neglected Tropical Diseases, 6(11), e1900. doi:10.1371/journal.pntd.0001900 [doi]
Gostic, Katelyn M; Wunder, Elsio A; Bisht, Vimla; Hamond, Camila; Julian, Timothy R; Ko, Albert I; Lloyd-Smith, James O, Mechanistic dose-response modelling of animal challenge data shows that intact skin is a crucial barrier to leptospiral infection., Philosophical transactions of the Royal Society of London. Series B, Biological sciences Vol.374, 2019
Gowen, B. B., Westover, J. B., Sefing, E. J., Bailey, K. W., Nishiyama, S., Wandersee, L., . . . Ikegami, T. (2015)., MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after rift valley fever virus infection in hamsters., rontiers in Microbiology, 6, 651. doi:10.3389/fmicb.2015.00651 [doi]
Rauch S, Roth N, Schwendt K, Fotin-Mleczek M, Mueller SO, Petsch B., mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents, bioRxiv 2020.10.23.351775; doi: https://doi.org/10.1101/2020.10.23.351775
Maccesi, Martina; Aguiar, Pedro H N; Pasche, ValĂŠrian; Padilla, Melody; Suzuki, Brian M; Montefusco, Sandro; Abagyan, Ruben; Keiser, Jennifer; MourĂŁo, Marina M; Caffrey, Conor R, Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery., Parasites & vectors Vol.12, 2019
Clouse, M. D., Shikiya, R. A., Bartz, J. C., & Kincaid, A. E. (2015)., Nasal associated lymphoid tissue of the syrian golden hamster expresses high levels of PrPC., PloS One, 10(2), e0117935. doi:10.1371/journal.pone.0117935 [doi]
Esmaili M, Tancowny BP, Wang X, Moses A, Cortez LM, Sim VL, Wille H, Overduin M., Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids, J Biol Chem. 2020 Jun 19;295(25):8460-8469. doi: 10.1074/jbc.RA119.012348. Epub 2020 May 1.
Andersen, K. K., Strokappe, N. M., Hultberg, A., Truusalu, K., Smidt, I., Mikelsaar, R. H., . . . Marcotte, H. (2015), Neutralization of clostridium difficile toxin B mediated by engineered lactobacilli that produce single-domain antibodies, Infection and Immunity, 84(2), 395-406. doi:10.1128/IAI.00870-15 [doi]
Hannaoui S, Triscott E, Duque VelĂĄsquez C, Chang SC, Arifin MI, Zemlyankina I, Tang X, Bollinger T, Wille H, McKenzie D, Gilch S., New and distinct chronic wasting disease strains associated with cervid polymorphism at codon 116 of the Prnp gene., PLoS Pathog. 2021 Jul 26;17(7):e1009795. doi: 10.1371/journal.ppat.1009795. eCollection 2021 Jul.
Davies KA, Welch SR, Sorvillo TE, Coleman-McCray JD, Martin ML, Brignone JM, Montgomery JM, Spiropoulou CF, Spengler JR., Optimal reference genes for RNA tissue analysis in small animal models of hemorrhagic fever viruses., Sci Rep. 2023 Nov 8;13(1):19384. doi: 10.1038/s41598-023-45740-w.
Tollefson, A. E., Ying, B., Spencer, J. F., Sagartz, J. E., Wold, W. S. M., & Toth, K. (2017), Pathology in permissive syrian hamsters after infection with species C human adenovirus (HAdV-C) is the result of virus replication: HAdV-C6 replicates more and causes more pathology than HAdV-C5, Journal of Virology, 91(10), 10.1128/JVI.00284-17. Print 2017 May 15. doi:e00284-17 [pii]
DeBuysscher, B. L., Scott, D., Thomas, T., Feldmann, H., & Prescott, J. (2016)., Peri-exposure protection against nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine, NPJ Vaccines, 1, 10.1038/npjvaccines.2016.2. Epub 2016 Jul 28. doi:16002 [pii]
Cortez LM, Morrison AJ, Garen CR, Patterson S, Uyesugi T, Petrosyan R, Sekar RV, Harms MJ, Woodside MT, Sim VL., Probing the origin of prion protein misfolding via reconstruction of ancestral proteins, Protein Sci. 2022 Dec;31(12):e4477. doi: 10.1002/pro.4477.
Magni R, Luchini A, Liotta L, Molestina RE., Proteomic analysis reveals pathogen-derived biomarkers of acute babesiosis in erythrocytes, plasma, and urine of infected hamsters, Parasitol Res. 2020 Jul;119(7):2227-2235. doi: 10.1007/s00436-020-06712-5. Epub 2020 May 21.
Pennitz P, Goekeri C, Trimpert J, Wyler E, Ebenig A, Weissfuss C, Mühlebach MD, Witzenrath M, Nouailles G., Protocol to dissociate healthy and infected murine- and hamster-derived lung tissue for single-cell transcriptome analysis, STAR Protoc. 2022 Dec 20;4(1):101957. doi: 10.1016/j.xpro.2022.101957. [Epub ahead of print]
Pennitz P, Goekeri C, Trimpert J, Wyler E, Ebenig A, Weissfuss C, Mühlebach MD, Witzenrath M, Nouailles G., Protocol to dissociate healthy and infected murine- and hamster-derived lung tissue for single-cell transcriptome analysis., STAR Protoc. 2023 Mar 17;4(1):101957. doi: 10.1016/j.xpro.2022.101957. Epub 2022 Dec 20.
Dacon C, Peng L, Lin TH, Tucker C, Lee CD, Cong Y, Wang L, Purser L, Cooper AJR, Williams JK, Pyo CW, Yuan M, Kosik I, Hu Z, Zhao M, Mohan D, Peterson M, Skinner J, Dixit S, Kollins E, Huzella L, Perry D, et al., Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses., Cell Host Microbe. 2023 Jun 14;31(6):1071-1072. doi: 10.1016/j.chom.2023.05.016. No abstract available.
Li H, Abraham A, Gazzola D, Hu Y, Beamer G, Flanagan K, Soto E, Rus F, Mirza Z, Draper A, Vakalapudi S, Stockman C, Bain P, Urban JF Jr, Ostroff GR, Aroian RV., Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans, Antimicrob Agents Chemother. 2020 Dec 14:AAC.01469-20. doi: 10.1128/AAC.01469-20. Online ahead of print.
Crosby, C. M., Matchett, W. E., Anguiano-Zarate, S. S., Parks, C. A., Weaver, E. A., Pease, L. R., . . . Barry, M. A. (2017)., Replicating single-cycle adenovirus vectors generate amplified influenza vaccine responses., Journal of Virology, 91(2), 10.1128/JVI.00720-16. Print 2017 Jan 15. doi:e00720-16 [pii]
Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH 3rd, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Graham R, Edwards CE, Tse LV, Okuda K, Markmann AJ, Bartelt L, de Silva A, Margolis DM, Boucher RC, Randell SH, Suzuki T, Gralinski LE, Kawaoka Y, Baric RS., SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo, Science. 2020 Nov 12:eabe8499. doi: 10.1126/science.abe8499. Online ahead of print.
Chan JF, Zhang AJ, Yuan S, et al., Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility., Clin Infect Dis. 2020 Mar 26. pii: ciaa325. doi: 10.1093/cid/ciaa325.
Welch SR, Spengler JR, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Scholte FEM, Rodriguez SE, O'Neal TJ, Ritter JM, Ficarra G, Davies KA, Kainulainen MH, Karaaslan E, Bergeron É, Goldsmith CS, Lo MK, Nichol ST, Montgomery JM, Spiropoulou CF., Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination., Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057. Epub 2023 Aug 4.
Brocato RL, Kwilas SA, Josleyn MD, Long S, Zeng X, Perley CC, Principe LM, Somerville B, Cohen MV, Hooper JW., Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines., Vaccine. 2021 Feb 12;39(7):1101-1110. doi: 10.1016/j.vaccine.2021.01.002. Epub 2021 Jan 19.
Sampieri, F., Vannucci, F. A., Allen, A. L., Pusterla, N., Antonopoulos, A. J., Ball, K. R., . . . Gebhart, C. J. (2013)., Species-specificity of equine and porcine lawsonia intracellularis isolates in laboratory animals., Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire, 77(4), 261-272.
Kincaid, A. E., Ayers, J. I., & Bartz, J. C. (2016)., Specificity, size, and frequency of spaces that characterize the mechanism of bulk transepithelial transport of prions in the nasal cavities of hamsters and mice., Journal of Virology, 90(18), 8293-8301. doi:10.1128/JVI.01103-16 [doi]
Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, Kalveram B, Freiberg AN, Menachery VD, Xie X, Plante KS, Weaver SC, Shi PY., Spike mutation D614G alters SARS-CoV-2 fitness, Nature. 2020 Oct 26. doi: 10.1038/s41586-020-2895-3. Online ahead of print.
Medina-Colorado, A. A., Osorio, E. Y., Saldarriaga, O. A., Travi, B. L., Kong, F., Spratt, H., . . . Melby, P. C. (2017)., Splenic CD4+ T cells in progressive visceral leishmaniasis show a mixed effector-regulatory phenotype and impair macrophage effector function through inhibitory receptor expression., PloS One, 12(1), e0169496. doi:10.1371/journal.pone.0169496 [doi]
Baseler, L., de Wit, E., Scott, D. P., Munster, V. J., & Feldmann, H. (2015)., Syrian hamsters (mesocricetus auratus) oronasally inoculated with a nipah virus isolate from bangladesh or malaysia develop similar respiratory tract lesions., Veterinary Pathology, 52(1), 38-45. doi:10.1177/0300985814556189 [doi]
Baseler, L., de Wit, E., Scott, D. P., Munster, V. J., & Feldmann, H. (2015)., Syrian hamsters (mesocricetus auratus) oronasally inoculated with a nipah virus isolate from bangladesh or malaysia develop similar respiratory tract lesions., Veterinary Pathology, 52(1), 38-45. doi:10.1177/0300985814556189 [doi]
Imai M, Iwatsuki-Horimoto K, Hatta M, et al., Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development, Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development [published online ahead of print, 2020 Jun 22]. Proc Natl Acad Sci U S A. 2020;202009799. doi:10.1073/pnas.2009799117
Garland M, Hryckowian AJ, Tholen M, Bender KO, Van Treuren WW, Loscher S, Sonnenburg JL, Bogyo M., The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI, Cell Rep Med. 2020 Apr 21;1(1):100005. doi: 10.1016/j.xcrm.2020.100005.
Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F., The Development of a Novel Nanobody Therapeutic for SARS-CoV-2, bioRxiv. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. Preprint.
Perley, Casey C; Brocato, Rebecca L; Kwilas, Steven A; Daye, Sharon; Moreau, Alicia; Nichols, Donald K; Wetzel, Kelly S; Shamblin, Joshua; Hooper, Jay W;, Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses., PloS one Vol.14, 2019
Welch SR, Ritter JM, Schuh AJ, Genzer SC, Sorvillo TE, Harmon JR, Coleman-McCray JD, Jain S, Shrivastava-Ranjan P, Seixas JN, Estetter LB, Fair PS, Towner JS, Montgomery JM, Albariño CG, Spiropoulou CF, Spengler JR., Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease, Antiviral Res. 2023 Jan;209:105490. doi: 10.1016/j.antiviral.2022.105490. Epub 2022 Dec 12.
Welch SR, Ritter JM, Schuh AJ, Genzer SC, Sorvillo TE, Harmon JR, Coleman-McCray JD, Jain S, Shrivastava-Ranjan P, Seixas JN, Estetter LB, Fair PS, Towner JS, Montgomery JM, Albariño CG, Spiropoulou CF, Spengler JR., Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease., Antiviral Res. 2023 Jan;209:105490. doi: 10.1016/j.antiviral.2022.105490. Epub 2022 Dec 12.
Ying, B., Toth, K., Spencer, J. F., Aurora, R., & Wold, W. S. (2015)., Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected syrian golden hamsters., Virology, 485, 305-312. doi:10.1016/j.virol.2015.07.024 [doi]
Chaparro V, Leroux LP, Masvidal L, Lorent J, Graber TE, Zimmermann A, Arango Duque G, Descoteaux A, Alain T, Larsson O, Jaramillo M., Translational profiling of macrophages infected with Leishmania donovani identifies mTOR- and eIF4A-sensitive immune-related transcripts, PLoS Pathog. 2020 Jun 1;16(6):e1008291. doi: 10.1371/journal.ppat.1008291. eCollection 2020 Jun.
Slough MM, Li R, Herbert AS, Lasso G, Kuehne AI, Monticelli SR, Bakken RR, Liu Y, Ghosh A, Moreau AM, Zeng X, Rey FA, Guardado-Calvo P, Almo SC, Dye JM, Jangra RK, Wang Z, Chandran K., Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection., Nat Commun. 2023 Jul 24;14(1):4454. doi: 10.1038/s41467-023-40126-y. Erratum in: Nat Commun. 2023 Sep 22;14(1):5924.
Wahl-Jensen, V., Bollinger, L., Safronetz, D., de Kok-Mercado, F., Scott, D. P., & Ebihara, H. (2012), Use of the syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers., Viruses, 4(12), 3754-3784. doi:10.3390/v4123754 [doi]
Toth, K., Ying, B., Tollefson, A. E., Spencer, J. F., Balakrishnan, L., Sagartz, J. E., . . . Wold, W. S. (2015)., Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male syrian hamsters, Viruses, 7(3), 1409-1428. doi:10.3390/v7031409 [doi]
Ellison, T. J., Talbott, G. C., & Henderson, D. R., VaxiPatchâ˘, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017, Vaccine 38, no. 43 (2020): 6839-6848.
Miller LJ, Nasar F, Schellhase CW, et al., Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs, Miller LJ, Nasar F, Schellhase CW, et al. Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs. Am J Trop Med Hyg. 2018;98(3):864-867. doi:10.4269/ajtmh.17-0686
Metabolism
Alò R, Fazzari G, Zizza M, Avolio E, Di Vito A, Olvito I, Bruno R, Canonaco M, Facciolo RM., Emotional and Spontaneous Locomotor Behaviors Related to cerebellar Daidzein-dependent TrkB Expression Changes in Obese Hamsters, Cerebellum. 2022 Jul 6. doi: 10.1007/s12311-022-01432-1. Online ahead of print.
Hoffman S, Alvares D, Adeli K., GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein, Mol Metab. 2022 Nov;65:101590. doi: 10.1016/j.molmet.2022.101590. Epub 2022 Sep 5.
Grande EM, Raka F, Hoffman S, Adeli K., GLP-2 Regulation of Dietary Fat Absorption and Intestinal Chylomicron Production via Neuronal Nitric Oxide Synthase (nNOS) Signaling, Diabetes. 2022 Jul 1;71(7):1388-1399. doi: 10.2337/db21-1053.
Horne RG, Yu Y, Zhang R, Abdalqadir N, Rossi L, Surette M, Sherman PM, Adeli K., High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian Hamsters, Nutrients . 2020 Nov 20;12(11):3557. doi: 10.3390/nu12113557.
Reitsema VA, Oosterhof MM, Henning RH, Bouma HR., Phase specific suppression of neutrophil function in hibernating Syrian hamster., Dev Comp Immunol. 2021 Jun;119:104024. doi: 10.1016/j.dci.2021.104024. Epub 2021 Jan 24.
de Vrij EL, Bouma HR, Goris M, Weerman U, de Groot AP, Kuipers J, Giepmans BNG, Henning RH., Reversible thrombocytopenia during hibernation originates from storage and release of platelets in liver sinusoids., J Comp Physiol B. 2021 May;191(3):603-615. doi: 10.1007/s00360-021-01351-3. Epub 2021 Mar 4.
Oncology
Phillips LM, Li S, Gumin J, Daou M, Ledbetter D, Yang J, Singh S, Parker Kerrigan BC, Hossain A, Yuan Y, Gomez-Manzano C, Fueyo J, Lang FF., An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus., Neuro Oncol. 2021 Nov 2;23(11):1911-1921. doi: 10.1093/neuonc/noab128.
Kudling TV, Clubb JHA, Quixabeira DCA, Santos JM, Havunen R, Kononov A, Heiniö C, Cervera-Carrascon V, Pakola S, Basnet S, Grönberg-Vähä-Koskela S, Arias V, Gladwyn-Ng I, Aro K, Bäck L, Räsänen J, Ilonen I, Borenius K, Räsänen M, Hemminki O, Rannikko A, Kanerva A, Tapper J, Hemminki A., Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression, Oncoimmunology. 2022 Jul 12;11(1):2096572. doi: 10.1080/2162402X.2022.2096572. eCollection 2022.
Pal R, Villarreal P, Yu X, Qiu S, Vargas G., Multimodal widefield fluorescence imaging with nonlinear optical microscopy workflow for noninvasive oral epithelial neoplasia detection: a preclinical study, J Biomed Opt. 2020 Nov;25(11):116008. doi: 10.1117/1.JBO.25.11.116008.
Quixabeira DCA, Zafar S, Santos JM, Cervera-Carrascon V, Havunen R, Kudling TV, Basnet S, Anttila M, Kanerva A, Hemminki A., Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control., Front Immunol. 2021 May 18;12:674400. doi: 10.3389/fimmu.2021.674400. eCollection 2021.
Woo Y, Reid V, Kelly KJ, Carlson D, Yu Z, Fong Y., Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer, Mol Ther Oncolytics. 2019 Dec 6;16:1-6. doi: 10.1016/j.omto.2019.11.003. eCollection 2020 Mar 27.
Surgical
Ruiz-Bedoya CA, Mota F, Ordonez AA, Foss CA, Singh AK, Praharaj M, Mahmud FJ, Ghayoor A, Flavahan K, De Jesus P, Bahr M, Dhakal S, Zhou R, Solis CV, Mulka KR, Bishai WR, Pekosz A, Mankowski JL, Villano J, Klein SL, Jain SK., 124I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection, Mol Imaging Biol. 2021 Aug 23:1-9. doi: 10.1007/s11307-021-01638-5. Online ahead of print.
Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, Wang T, Golding B., Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters., Clin Infect Dis. 2021 Sep 23. pii: ciab854. doi: 10.1093/cid/ciab854. [Epub ahead of print]
Toxicology
Langkilde, S., Schroder, M., Frank, T., Shepherd, L. V., Conner, S., Davies, H. V., . . . Poulsen, M. (2012)., Compositional and toxicological analysis of a GM potato line with reduced alpha-solanine content--a 90-day feeding study in the syrian golden hamster., Regulatory Toxicology and Pharmacology : RTP, 64(1), 177-185. doi:10.1016/j.yrtph.2012.06.018 [doi]
Fagiola M, Gu G, Avella J, Cantor J., Free lung desmosine: a potential biomarker for elastic fiber injury in pulmonary emphysema, Biomarkers. 2022 Jun;27(4):319-324. doi: 10.1080/1354750X.2022.2043443. Epub 2022 Feb 24.
Huber EA, Cerreta JM., Mechanisms of cell injury induced by inhaled molybdenum trioxide nanoparticles in Golden Syrian Hamsters, Exp Biol Med (Maywood). 2022 Dec;247(23):2067-2080. doi: 10.1177/15353702221104033. Epub 2022 Jun 25.
